Next Article in Journal
Association of rs699947 (−2578 C/A) and rs2010963 (−634 G/C) Single Nucleotide Polymorphisms of the VEGF Gene, VEGF-A and Leptin Serum Level, and Cardiovascular Risk in Patients with Excess Body Mass: A Case–Control Study
Previous Article in Journal
Objective Assessment of Counselling for Fetal Heart Defects: An Interdisciplinary Multicenter Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JCM
Volume 9
Issue 2
10.3390/jcm9020468
jcm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Microglial Function in the Effects of Early-Life Stress on Brain and Behavioral Development

by
Clarissa Catale
1,2,
Stephen Gironda
3,
Luisa Lo Iacono
1,2 and
Valeria Carola
2,4,*
1
Department of Psychology, University of Rome “Sapienza”, Via dei Marsi, 78, 00185 Rome, Italy
2
IRCCS Santa Lucia Foundation, Via Fosso di Fiorano 64, 00143 Rome, Italy
3
Department of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA
4
Department of Dynamic and Clinical Psychology, University of Rome “Sapienza”, Via degli Apuli 1, 00185 Rome, Italy
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2020, 9(2), 468; https://doi.org/10.3390/jcm9020468
Submission received: 27 December 2019 / Revised: 30 January 2020 / Accepted: 5 February 2020 / Published: 8 February 2020
(This article belongs to the Section Clinical Neurology)
Browse Figure
Versions Notes

Abstract

:
The putative effects of early-life stress (ELS) on later behavior and neurobiology have been widely investigated. Recently, microglia have been implicated in mediating some of the effects of ELS on behavior. In this review, findings from preclinical and clinical literature with a specific focus on microglial alterations induced by the exposure to ELS (i.e., exposure to behavioral stressors or environmental agents and infection) are summarized. These studies were utilized to interpret changes in developmental trajectories based on the time at which the stress occurred, as well as the paradigm used. ELS and microglial alterations were found to be associated with a wide array of deficits including cognitive performance, memory, reward processing, and processing of social stimuli. Four general conclusions emerged: (1) ELS interferes with microglial developmental programs, including their proliferation and death and their phagocytic activity; (2) this can affect neuronal and non-neuronal developmental processes, which are dynamic during development and for which microglial activity is instrumental; (3) the effects are extremely dependent on the time point at which the investigation is carried out; and (4) both pre- and postnatal ELS can prime microglial reactivity, indicating a long-lasting alteration, which has been implicated in behavioral abnormalities later in life.

1. Introduction

Exposure to childhood adversities (i.e., abuse, neglect, physical illness, economic difficulty) is a risk factor for developing psychopathologies later in life. A history of early-life stress (ELS) is strongly associated with almost all classes of mental disorders, including mood disorders, anxiety disorders, and substance use disorders [1]. Biological embedding such as alterations in brain structure, function, connectivity, and epigenetic programming has been consistently reported in individuals exposed to adversities in childhood [2,3]. It has been suggested that exposure to ELS could modify the trajectories of brain maturation [4,5,6], increasing vulnerability to psychopathologies later in life. However, neurobiological mechanisms underlying the emergence of these changes have been poorly characterized. Recently, microglial cells have been proposed as mediators of the neurodevelopmental abnormalities induced by ELS exposure [7]. Microglia are the resident macrophages of the brain, which scan the surrounding extracellular space to maintain homeostasis [8]. If a danger signal is encountered, these cells undergo rapid morphological and functional changes (phenotypic changes) that include the phagocytosis of triggering stimuli and the synthesis and secretion of inflammatory mediators. During development, microglia are extremely active and contribute intensively to shaping and refining the developing neural circuits by regulating neurogenesis, synaptogenesis, synaptic pruning, and ultimately behavior [9,10,11,12]. Changes in microglial function during development have been demonstrated to affect these processes [13,14]. Crucially, accumulating evidence has reported that ELS can perturb microglia and their activity. In this review, we summarize the literature surrounding ELS and microglia to explore the role of these cells in ELS-induced aberrant development (Figure 1). We describe preclinical data showing the impact of pre- and postnatal adversities, in the form of harmful environmental stimuli, on microglia in rodents. Moreover, we report studies providing evidence for altered microglial–neuronal communication and microglia-dependent behavioral alterations following ELS. Finally, we discuss clinical findings in the field.

2. Discussion

2.1. Early-Life Stress and Microglia: Preclinical Studies

As sensors of the surrounding environment, microglia are highly responsive to local perturbations. These perturbations can drive different reactive states in microglia through morphological and functional changes. Interestingly, environmental stressors other than immune stimuli can trigger a microglial response, and this phenomenon has been proposed to contribute to shaping the organism’s response to threats [15]. Indeed, microglial receptors’ repertoire allows them to sense and respond to signaling from stress-reactive networks, including the endocrine, immune, and nervous systems [15,16].
When occurring in early life, stress can induce different microglial responses that may result in two main consequences. First, interfering with microglial phagocytic activity and neuronal–microglial signaling can disrupt neural circuits’ developmental trajectories and alter the formation of behavior [17]. Second, aberrant functionality of maturing microglial cells can alter their developmental programs, with long-lasting consequences for their reactivity. Indeed, stress exposure in early life can “prime” microglia to be more responsive to subsequent challenges later in life, leaving a permanent memory of the stressful experience with only partially known consequences in adulthood [17,18].
In rodent models, multiple ELS manipulations (i.e., exposure to behavioral stressors or environmental agents and infection) have been shown to induce microglial changes in offspring. In this review, we explore similarities and divergences in preclinical evidence surrounding pre- and postnatal stress effects on microglia, based on the type of ELS procedure employed, the developmental timing with which the stress was introduced, and the time point at which the effects were examined. Specifically, we have categorized stress into two major groups. The first, behavioral stressors, includes paradigms that have been proven to induce activation of the hypothalamic–pituitary–adrenal axis (i.e., increased corticosterone in rodents) or administration of molecules of the stress response pathway (i.e., glucocorticoids) that mimics a stressful condition. The second category, environmental agents and infection, consists of factors such as exposure to poor diet, drugs of abuse, chemicals, and immune activators which have been demonstrated to affect development. Within this categorization, differences between early/short-term effects measured immediately after the stress exposure and late/long-term effects measured later in life are discussed, along with resulting differences in sex-specific outcomes.
Microglial alterations that have been more commonly investigated include cell density changes and immunophenotypic shifts, as reflected by consistent variations in cell morphology and expression of microglial markers. These changes have been mostly detected by ex vivo immunohistochemical analysis, using antibodies that recognize such markers, including ionized calcium-binding adapter molecule (IBA-1) or clusters of differentiation (CD) molecules, such as complement receptor 3 (CD11b/c), CD68, and CD74. Specifically, morphological and transcriptional variations characterize the “activated” microglia, which usually display reduced length, thicker processes, and larger cell somas (hypertrophic/bushy microglia) or no processes (amoeboid), compared to resting microglia, which are small-bodied and highly ramified [16]. Notably, during development, the degree of ramification reflects the maturity of microglial cells, and an amoeboid morphology is thought to reflect an immature phenotype [19,20].
Few studies have examined the transcriptional changes of signaling molecules implicated in microglial–neuronal interactions, such as the fractalkine (CX3CL1)/fractalkine receptor (CX3CR1) system, the CD200/CD200R system, and the P2Y purinergic receptor 12 (P2Y12) [21,22].
To investigate the impact of ELS-induced microglial alterations on brain and behavior development, studies have mostly used minocycline as a pharmacological tool with which to prevent or counteract microglial activation. Despite its low specificity (effects on other immune cells, subtle effects on astroglial activation) and controversial mechanism of action (possible effects on microbiota), minocycline has been primarily used in the past—and still is—thanks to its favorable kinetic properties and its relatively low cost [23,24,25]. Very few studies have applied methodologies for analysis of the specific contribution of microglia/macrophages, rather than other cells, in these processes. These techniques include, for example, new pharmacological tools that reversibly ablate microglia, such as inhibitors of colony-stimulating factor 1 receptor (CSF1R; e.g., GW2580).
Finally, only one clinical study to date has specifically analyzed microglia in individuals who have been exposed to ELS. This study employed the positron emission tomography (PET) radioligand [11C]PBR28, which binds to the 18 kDa mitochondrial translocator protein (TSPO), which is thought to be expressed in active microglia during brain injury and neurodegeneration and is considered a marker of neuroinflammation [26,27].

2.1.1. Prenatal Behavioral Stressors

The earliest evidence suggesting a relationship between prenatal stress and microglia was posited in 2010 by Gómez-González and Escobar. In their study, pregnant rats were exposed to a forced swimming task throughout gestation. The exposure to stress via the dam induced a brain-region-specific effect on microglia of postnatal day (P)1 offspring. An overall decrease in microglial cell number and a reduction in amoeboid microglia were observed in the corpus callosum. Instead, an increase in the number of microglial cells (mainly ramified) was detected in the entorhinal and parietal cortices, the septum, amygdala (AMY), and thalamus [28].
Since Gómez-González and Escobar (2010), few studies have considered the effects of prenatal behavioral stress on microglial activation. Studies conducted by Zhao et al. (2014, 2015) investigated the effects of maternal sleep deprivation (three-hour deprivation starting at embryonic day, E, 18 until birth) on pup microglia at P21. This manipulation resulted in a 30% increase in microglial density and retracted thicker processes in the hippocampus (HIP) [29,30].
Consistent with these results, maternal restraint stress (from E12–P21) in female mice produced a 40% increase in microglia, larger somas, and shortened branching in the pup HIP [31].

2.1.2. Prenatal Environmental Agents and Infection

The maternal immune activation (MIA) model [32] has been used to explore the immediate and late effects of prenatal stress on microglia [33]. Interestingly, microglia have been implicated in the vulnerability of MIA offspring to developing neuroimmune and behavioral abnormalities, especially after exposure to a second stressful challenge later in life [34,35,36,37,38,39]. Evidence suggests that poly (I:C) injections (a commonly used MIA model) at E9 increase amoeboid microglial cells in both sexes at P62 [36]. However, a sex-dependent long-term sensitivity to this stress was demonstrated in more recent studies, as this phenotype was still visible at P90 only in males in the HIP [40]. Moreover, the expression of CX3CR1 in the HIP was only reduced in P15 males exposed to lipopolysaccharide (LPS, another MIA model) injection at E9 [39]. These findings generally support a common effect of MIA on microglia. However, research suggests that there may be critical periods of development during gestation in which microglia are more sensitive to dysregulation induced by MIA. For example, minocycline treatment in adulthood has been shown to rescue alterations in microglia activation after poly (I:C) injections at E9 but not E15 [34,36]. Moreover, LPS injection at E13.5 is not able to increase microglia cell numbers in the somatosensory cortex of P7 mice [40].
In contrast to the studies above, Giovanoli et al. (2013) found that poly (I:C) injection (E9) alone was not sufficient to induce microglial activation (P56). However, when this procedure was combined with peripubertal variable stress, an activated microglial phenotype was observed in the HIP and prefrontal cortex (PFC) at P41 through increased expression of specific markers and soma enlargement [41]. Minocycline during peripubertal stress exposure was found to ameliorate the effects of the combined stress on microglia activation [37].
Consistent with these findings, injection of poly (I:C) at E15 enhances microglial activation in the HIP and increases cell density in the corpus callosum at P180 [35].
Diet is a critical determinant of neonatal brain development, and a poor diet is the most common cause of immunodeficiency [42]. A Western high-fat diet (HFD) consisting of 40% fat provided to the dam throughout gestation until P21, in conjunction with limited nesting material, induced significant pro-inflammatory alterations to microglia in the HIP of both sexes at P21, including increases in cell number and in IBA-1 and toll-like receptor (TLR) 9 expression [43]. In a study by Edlow et al. (2019), however, an analogous HFD regimen similarly altered microglia cells in the HIP only in male but not female rats at E17 [44].
A combination of perinatal brain injury induced by a gestational low-protein diet and postnatal injections of interleukin-1β (IL-1β), caused an upregulation of inflammation-related gene sets and an increase in microglial cell number in cortical white matter at P4. Cultured microglial cells from P2 low-protein-diet animals displayed a more amoeboid morphology and released higher concentrations of several pro-inflammatory cytokines with respect to controls [45].
Prenatal exposure to alcohol induces significant alterations to microglia activity [46]. Evidence suggests that prenatal alcohol through maternal exposure during gestation causes an increase in microglial cell number and activation at E15.5 and P3 [46].
Studies have sought to combine prenatal exposure to diesel exhaust particles and HFD throughout adolescence to investigate how these environmental factors can influence microglia activity and behavior [47,48]. These studies demonstrated that diesel exhaust particles and HFD increased microglial density, and colocalization of microglia and neurons in the HIP of males while having no effect on females at P63. Although this was consistent with other HFD studies [43,44], further evidence presented by Bolton et al. (2017) showed that diesel exhaust particles were sufficient to induce these changes to microglial activity without a high-fat diet, which may, in part, have been due to a dysregulation in TLR4 signaling [48].

2.1.3. Effects of Prenatal-Stress-Induced Microglial Alterations on Brain and Behavior

Although there has been little investigation on the effect of prenatal stress on microglial alterations and their impact on circuit formation and behavior, several studies have demonstrated effects. Zhao et al. (2014, 2015) demonstrated that maternal sleep deprivation increases microglia count, anhedonia-like behavior, impairments to spatial learning and memory, and decreases neurogenesis at P21. In a follow-up study, minocycline was shown to recover deficits in both behavior and neurogenesis, suggesting that maternal sleep deprivation’s effects are microglia-dependent [29,30].
Prenatal exposure to alcohol reduces mRNA expression of signal transducers such as CX3CL1, insulin-like growth factor 1, and brain-derived neurotrophic factor (BDNF) in the HIP [46].
Thion and colleagues (2019) recently showed that prenatal LPS injection (E13.5) and embryonic microglia depletion (E6.5/E7.5 injection of an antibody that targeted the CSF1R) induced remarkably similar alterations in parvalbuminergic interneuron wiring in the somatosensory barrel cortex, suggesting that MIA effects could result from an inability of microglia to fulfill their standard physiological roles [40]. In addition, a poly (I:C) injection at E15 resulted in an adult-like microglial transcriptome across the brain at P1 [49], while the same injection at E14 caused a reduction in gene expression related to cell activation, immune response, motility, and phagocytosis in adulthood [50]. Regarding behavior, pups prenatally exposed to poly (I:C) showed an alteration in startle response, repetitive behavior, and locomotor activity [34,35,36,37,38,39], which were then rescued by postnatal minocycline treatment [30,34,36,37] (see Table 1 for a summary).

2.1.4. Postnatal Behavioral Stressors

The first studies exploring the effects of postnatal stress on microglia investigated the responses of these cells to early glucocorticoids in order to mimic a psychological stress condition. In 1955, Field showed that exposure to the stress hormone cortisone in newborn (P3–5) rats reduced microglial cells [51]. In 1982, Ling confirmed and expanded these results, reporting a 50% reduction in the number of amoeboid (immature) microglia in the corpus callosum two days after the cortisone injection, and a complete absence from the fifth postnatal day onwards. Interestingly, at the same time point, most microglial cells observed displayed a ramified and mature morphology, usually appearing later in life [52].
Similarly to cortisone, early postnatal administration of the synthetic glucocorticoid dexamethasone reduced 40%–60% of the number of amoeboid microglia in the corpus callosum of rats (P4, 7). This was associated with a transient reduction in microglial cell proliferation, an increase in microglial cell death, and acceleration of their maturation, which returned to control levels by P8 [53,54].
More recently, studies investigating the effects of behavioral stress procedures in early life have found a general increase in the number and activation of microglial cells across brain areas. Stressing the mouse dam through the limitation of nesting and bedding material in the cage induces microglia changes in the pup [55,56]. Early effects comprise reduced processes complexity in the HIP, suggesting the presence of an amoeboid phenotype and reduced number in the entorhinal cortex [56]. However, the late effects of this paradigm have not been reported if not in combination with another early environmental manipulation (unbalanced fatty acid diet), in which limited bedding induced an increase in microglia in the adult HIP [55]. A series of ex vivo investigations on the early effects of maternal separation (MS) on microglia showed a general increase in the proportion of cells with an activated morphology (amoeboid/hypertrophic, with large somas and thick short processes) across central nervous system (CNS) regions such as the HIP [57,58,59] and the medulla [60]. Interestingly, in one of these studies, microglial amoeboid morphology was not associated with an augmented phagocytic activity measured in vitro [58]. The impact of MS on the number of microglial cells is not as clear, with studies reporting an increase [58,61], a decrease [59], or no effect [57] on the number of microglial cells or expression of IBA-1 in the HIP. These differential results can be species-specific (rat vs. mouse) or due to the subregion of the HIP considered. Interestingly, Chocyk and colleagues found a decrease in the number of apoptotic microglia cells (expressing the active caspase-9+ marker and exhibiting the morphological hallmarks of apoptosis) in the substantia nigra and ventral tegmental area of MS rats [62]. This suggests that the higher microglial cell count detected after MS could be primarily due to a reduction in microglial cell death, rather than a proliferation.
Several studies have demonstrated that MS exposure has lasting, likely permanent effects on microglia. In general, adult brains from MS mice do not present differences in the number of microglial cells, but show region-specific modulation in the expression of activation markers and phagocytic activity and motility. Specifically, MS induces long-term increases in the expression of IBA-1 in brain regions such as the PFC [61], the dorsal striatum, the nucleus accumbens, and the CA3 subregion of the HIP [63]. However, a decrease in IBA-1 expression was detected in the adult spinal cord from MS rats [64]. In an in vitro assay, hippocampal microglia from adult MS mice showed an increased phagocytic activity [58]. Capturing microglial cells in vivo, Takatsuru and colleagues (2015) showed that somatosensory stimulation in adulthood induced a significantly higher increase in the number of microglial processes formation (motility) in MS mice vs. controls [65]. This response could influence microglia–synapse interactions and, ultimately, neuronal functionality.
Finally, in order to better understand the molecular changes associated with morphological and densitometric alteration after ELS challenges, Delpech and colleagues profiled the gene expression of hippocampal microglia in MS mice (brief daily separation model) immediately after the stress procedure, revealing perturbation of several genes, including an increased expression of genes involved in cell cycle regulation and apoptosis (e.g., CSF1, CSF3R), microglial activation, and anti-inflammatory function, and a reduced expression of several pro-inflammatory genes. Exposure to brief daily separation also modified several phagocytosis-related genes, and some of these transcriptomic alterations were still present later in life [58].
The exposure to stress during adolescence, primarily in the form of social challenges, has a definite impact on microglial functionality, inducing a transient increase in microglial activity and then a decrease of microglial markers later in life. The study by Gong and collaborators (2018) showed that one day of brief social isolation at P14 was sufficient to increase microglial density in the HIP, likely by augmenting the proliferation of these cells. After four days of isolation (P14–17), cell number returned to control levels and microglia showed ongoing apoptotic processes. In adulthood, exposure to a week of brief social isolation (P14–21) induced a reduction in the number of microglial cells in the dentate gyrus (HIP). As a result of these findings, the authors suggested that brief social isolation during the third postnatal week triggers a complex process of activation and subsequent apoptosis of microglial cells, resulting in a significant loss of microglia in adults [66]. Similarly, social defeat in adolescent mice provokes an early augmentation in PFC IBA-1 and a subsequent reduction in microglial cells and IBA-1 expression in adulthood [67,68].
Our group (2018) demonstrated that a milder variant of the social defeat paradigm, when applied during the periadolescent period, is able to increase microglia number, IBA-1 expression, and soma size in the ventral tegmental area of pups. In adulthood, cell density returned to control levels, but microglia displayed increased soma size and process complexity close to the soma. Interestingly, the microglial cells of stressed mice showed a higher IBA-1 percentage of expression in response to cocaine injection (5 mg/kg) with respect to controls, indicating a possible effect of early social stress on microglial priming [69]. Differently, a paradigm of social instability stress applied during adolescence (isolation and change of cage partner) did not produce effects on counts of microglia in the dentate gyrus (HIP) either early or later after the stress exposure [70].
In order to evaluate how combined stressors during postnatal development affect microglia, MS has been followed by adolescence stress (AS) paradigms. In these studies, AS and AS paired with MS had a higher impact on microglia than MS alone. Han et al. (2019) observed that HIP microglia from MS mice tended toward a more hypertrophic phenotype and a lower CX3CR1 expression with respect to controls, and this effect became prominent after exposure to adolescent restraint stress [71]. These mice showed an increase in pro-inflammatory markers (inducible nitric oxide synthase, iNOS, tumor necrosis factor α, TNF-α, interferon gamma, IFN-γ, IL-6, and IL-1β) and downregulation of several anti-inflammatory markers (IL-4, transforming growth factor β, TGF-β, IL-1 receptor agonist, IL-1Rα, Ym-1, Arginase 1, Arg1) in the HIP, which were rescued by minocycline treatment. In another study with adolescent female rats, MS alone did not alter microglial number, but induced an activated phenotype in the PFC and HIP. In contrast, adolescent mild, variable stress increased microglial cell count, an effect that was further amplified in rats who underwent both the stressful procedures [72]. Finally, combining MS with adolescent food restriction was able to increase IBA-1 expression in the PFC of both sexes compared to only MS animals [73] (see Table 2 for a summary).

2.1.5. Postnatal Environmental Agents and Infection

A large body of literature focusing on alcohol exposure in early postnatal life describes an increase in microglial activation markers and phenotype changes in the cortical and subcortical regions of the brain immediately after treatment [77,78,79,80,81,82,83,84,85,86]. Regarding cell density, contrasting findings have been collected, with some studies showing an increase [78,86] and others a decrease [79,85,87] in the number of microglial cells in both cortical and subcortical compartments. It has also been shown that alcohol induces an increase in amoeboid microglia along with a decrease in resting microglia in the HIP and cerebellum [82]. Moreover, Ahlers and colleagues (2015) observed layer-specific differences of microglial responses to ethanol in the somatosensory cortex (increase/decrease in number, alteration of CD68 expression, and different morphologies) [88]. Notably, one study reported no acute or late effect of early postnatal alcohol exposure on microglial markers in the visual cortex [89].
Interestingly, adolescent binge drinking seems to have long-lasting effects on microglia [83,90], whereas the temporal extent of microglial activation in neonates exposed to alcohol is still not clear. Topper and colleagues reported that alcohol inhalation on P3–5 has transient effects on HIP and cerebellar microglial activation [82]. However, Chastain and colleagues (2019) observed an increase in microglia cell count in the hypothalamus of alcohol-fed pups (P2–6) that persisted into adulthood. At P6, this effect was associated with altered microglial gene expression, including augmented transcripts of IL-6, TNF-α, CSF1R, and TLR4. In adulthood, similar molecular alterations were detected only in alcohol-fed rats that received an LPS immune challenge later in life. These LPS-induced effects were rescued in animals administered minocycline during alcohol feeding, suggesting a priming effect of early ethanol on microglia [78].
Two studies identified contradictory results regarding sex differences in the microglial responses to early alcohol exposure. There is evidence of a female-specific increase in the number of HIP microglial cells in young (P5) rats acutely exposed to ethanol [86]. However, in mice, alcohol exposure had the same effects on microglia in both sexes [88].
Among opioid drugs, morphine has been shown to increase microglial TLR4 expression in the nucleus accumbens (not in the HIP), when administered in adolescence, but not adulthood. Adult morphine re-treatment increased CD11b expression solely in pre-exposed rats (priming effect) [91].
Early-life exposure to high doses of potentially toxic chemicals (GBR12909 [92], valproate [93], methylphenidate [94], manganese [95]) impacts microglia with very similar results in the short term. Specifically, increases in cell number, amoeboid/hypertrophic morphology, and expression of activation markers (CD68) have been found across brain regions, including frontal and other cortices, HIP, AMY, striatum, thalamus, substantia nigra, and globus pallidus [92,93,94,95,96].
However, discrepant results have been reported on the long-term effects, wherein studies demonstrated either a persistent increase in microglial activity (GBR12909 [92]) or no effect (manganese [95]).
Bacterial infection is one of the most common immune challenges occurring in early life. Exposure to LPS in the first postnatal week produces a rise in microglial cell density that lasts for a few days after the injection [97,98,99]. Pang and colleagues (2016) reported an acute LPS-induced increase in the number of microglial cells, which mostly colocalized with markers of an anti-inflammatory profile (TGF-β, CD206), except for few pro-inflammatory-profiled cells (expressing CD68, major histocompatibility complex-II, iNOS) [99]. Claypoole et al. (2017) found sex differences in this response, with increase found only in female HIP [97]. Notably, the timing of LPS exposure is determinant for microglial responses, given that injection at P2, but not at P21, results in an immediate increase in microglial activation markers (CD11a, F4/80, CD172a, SLAM family member 7) [100]. The authors suggested that this increased neuroinflammatory response to bacterial molecules in neonatal but not periadolescent pups may underlie the sensitivity to infection that characterizes early postnatal neurodevelopment. Additionally, early LPS administration has been shown to have a long-lasting effect on microglial responses: injection applied during the first or second postanal week increases microglial cell density, IBA-1 expression, and hypertrophic morphology later in life, registered in the PFC [101,102], HIP [101,103,104], and substantia nigra [105,106,107]. Moreover, high colocalization between apoptosis-associated speck-like protein (ASC, part of the NLRP3 inflammasome) and IBA-1 was found in adolescent brains from LPS-exposed rats [101], suggesting an effect on apoptotic pathways in microglia.
Seminal works from Bilbo and colleagues shed light on numerous effects of early postnatal immune activation on microglial function and related behavior. Using a model of neonatal infection (NI) through Escherichia coli (E. coli, a Gram-negative bacterium) exposure at P4, they reported a marked increase in microglial activation markers (CD11b mRNA) within the HIP of NI rats early after the infection. This increase persisted into adulthood and was exaggerated by a second challenge with LPS [108,109]. Moreover, the HIP from NI pups exhibited a higher count of microglial cells, which were shown to be active and proliferating [110], but this number returned to control levels in adolescence. However, in adult NI mice, microglia exhibited an altered profile, with larger cell volumes; shorter, thicker processes; and sustained increase in the expression of activation markers [107,108,109]. These long-term alterations are associated with sensitized microglia and, indeed, microglia from NI mice show exaggerated reactivity to various types of stimuli that function as a second challenge later in life, from LPS [108,109] to amphetamine [111] and fearful stimuli [112].

2.1.6. Effects of Postnatal-Stress-Induced Microglial Alterations on Brain and Behavior

In the context of ELS, it is crucial to understand the possible mechanisms by which altered microglial activity can, in its turn, influence neuronal function and behavior. However, the literature still lacks an integrative understanding of microglial responses to postnatal ELS and their effects on brain and behavior development. Very few studies have analyzed the impact of MS on microglial–neuronal interaction, showing region-specific effects in the CNS. For example, Han and colleagues (2019) investigated the molecular profiles of HIP microglia in mice exposed to MS, showing decreased expression of genes involved in microglial–neuronal communication, such as CX3CR1, immediately after the stress procedure. This effect was exacerbated by exposure to adolescent restraint stress [71]. In contrast, no changes in expression of the CX3CL1/CX3CR1 pathway were observed in medullar microglia from MS mouse pups [60]. A combination of MS with neonatal handling, which increased maternal care towards the pups, induced a decrease in CX3CL1 expression in the nucleus accumbens (but not the HIP) of adult rats. Interestingly, microglial activation in this structure was associated with behavioral alterations consisting of attenuation of morphine-induced reinstatement of conditioned place preference [75].
Several studies have implicated microglia in the process that links AS to the brain and behavioral alterations later in life. In a model of adolescent sleep deprivation, decreases in CX3CR1, CD11b, and P2Y12 were observed in the HIP of young mice, with no alteration in CSF1R levels or microglial cell density. In parallel, an increased density of excitatory synapses and reduced CD68 expression was observed. This was associated with reduced engulfment of postsynaptic density by microglia in adolescence but not in adulthood [76]. Chronic social isolation starting at weaning induced an increase in the expression of IBA-1 and CD11b and a decrease in CD200R mRNA in the HIP of rats, along with neuronal epigenetic alterations that were rescued by poststress minocycline treatment [74]. Moreover, minocycline could inhibit the reduction in proliferative neuronal cells, and the downregulation of BDNF was detected in the HIP of juvenile mice that underwent combined MS and AS procedures [71]. In parallel, this treatment could also rescue stress-induced depressive-like (but not anxiety-like) behavior. Similarly, minocycline decreased the levels of depressive-like behavior in socially isolated rodents [66,74]. Minocycline treatment during adolescent social defeat rescued cognitive deficits observed in adulthood [67]. Recently, our group (2018) demonstrated that periadolescent social stress-induced microglial activation mediated dopaminergic system dysfunctionality and cocaine-induced behavioral alterations. Indeed, these effects were rescued by either minocycline or GW2580 (selective inhibitor of CSF1R) administration during the stress procedure [69].
Regarding other harmful forms of ELS, Ahlers and colleagues (2015) reported an increase in the contacts between microglia and apoptotic pyramidal cells in the somatosensory cortex after exposure to early postnatal ethanol, suggesting the engulfment of neuronal residues by microglia. Moreover, they demonstrated that microglial activation was driven by alcohol-induced apoptotic cell death, and not by the direct effects of alcohol on microglia [88]. In an experiment of neonatal immune activation, minocycline pretreatment before LPS injection failed to rescue the locomotor, anxiety, and depression-like behavioral alterations in adult mice [102]. However, a more extended treatment (minocycline exposure pre- and post LPS injection) significantly attenuated LPS-induced brain injury and improved neurobehavioral performance in P21 rats [106]. Bilbo and colleagues extensively characterized the molecular profiles of sensitized microglia in the E. coli model of NI. A region-specific modulation of the CD200/CD200R and CX3CL1/CX3CR1 pathways in adult NI rats was observed in nucleus accumbens and HIP microglia cells following a second challenge with amphetamine or a fearful stimulus later in life [111,112]. Interestingly, animals exposed to NI and LPS showed memory impairments in a fear conditioning protocol, which were prevented by minocycline treatment before the LPS.
Drugs of abuse such as morphine can sensitize microglia when administered in early life. Indeed, inhibiting microglial activation through ibudilast (but not minocycline) co-injection during adolescence attenuates morphine-induced glial activation and behavioral responses in adult rats [91]. (see Table 3 for a summary)

2.1.7. Early Preventative Interventions

As a result of the growing body of evidence suggesting the role of microglia in mediating the effects of ELS on psychopathological behavior, it has become essential to develop and test potential interventions that can directly target these cells [113]. In this section, we discuss several preclinical rodent studies that explored the capability of different pharmacological and environmental manipulations of mitigating microglial activation induced by exposure to ELS.
Environmental enrichment (EE) has been widely investigated for its efficacy in preventing the effects of ELS on maladaptive behavioral phenotypes in adulthood [114,115,116,117]. The mechanism by which EE exerts this effect is poorly understood. Preclinical evidence suggests that EE may ameliorate the effects of ELS by interacting with the immune system and preventing elevations in circulating pro-inflammatory cytokines TNF-α, IL-1β, and IL-10 [118,119]. While there is limited evidence linking ELS, EE, and microglia dysregulation, EE has been shown to reduce microglial proliferation compared with standard housing in brain regions such as the AMY and the HIP and to modulate microglia density in the cerebral cortex [120,121]. Interestingly, EE failed to prevent long-term alterations to microglial density due to prenatal LPS injections [122], but prevented the elevation of pro-inflammatory cytokines and phagocytic activity when LPS was administered during adolescence and adulthood in the HIP [123,124]. This evidence suggests that EE may only be useful as a treatment model for certain ELS at specific developmental periods.
Oxytocin (OXT) is a peptide hormone that plays a significant role in social bonding, sexual reproduction, childbirth, and early development. As a result of ELS, OXT pathways in the hypothalamus, AMY, and PFC are disrupted [125,126]. While there is little evidence identifying how the administration of OXT affects behavior after ELS, there is a growing body of literature suggesting that it may serve as a useful target for both pharmacotherapy and prevention. Yuan et al. (2016) demonstrated that intranasal administration of OXT to adult mice reduced microglial activation and pro-inflammatory cytokine expression induced by an LPS injection in the PFC of adult mice. In addition, the authors demonstrated that OXT could reduce LPS-induced activation both in primary microglia and in microglial cell lines [127]. Recently, Amini-Khoei et al. (2017) demonstrated that intracerebral administration of OXT reduced pro-inflammatory gene expression related to microglia activity, including TNF-α, IL-1β, and TLR4, in the HIP of adult animals exposed to MS [128]. In a double-hit model using a low-protein diet to induce perinatal brain damage followed by postnatal injections of IL-1β during early life, the accompanying administration of the OXT receptor agonist carbetocin was found to prevent microglial activation and reduce the effects of the low-protein diet and IL-1β injections on genes associated with microglial activation throughout the brain [45].
Galantamine is a tertiary alkaloid that acts as a reversible and competitive inhibitor of the alpha 7-nicotinic acetylcholine receptors (α7-nAChrRs) [129]. Through this receptor subunit on microglia, galantamine has been demonstrated to modulate microglia activation [130,131]. While galantamine has been most widely explored as a treatment for Alzheimer’s disease [132], there is growing evidence that it can help to regulate microglia and ameliorate the behavioral effects related to ELS [131,133,134,135,136,137]. Oral administration of galantamine during adolescence reversed memory deficits in adulthood caused by maternal separation [134] and ameliorated the effects of perinatal exposure to kynurenic acid on cognitive flexibility in a mouse model of schizophrenia [137].
Melatonin is a hormone that is mainly secreted through the pineal gland [138]. Preclinical work suggests that melatonin can reduce microglial alterations in brain regions such as the AMY, hypothalamus, ipsilateral basal cortex, and HIP [139,140,141]. Melatonin can modulate microglia density and morphology as well as phagocytic response to LPS in the HIP both in adulthood [142,143] and in early life [102]. Furthermore, melatonin treatment during gestation has attenuated microglia activation in the HIP as a result of umbilical cord occlusion in early life, and kainic acid administration via intraperitoneal injection in adulthood [144,145].
Long-chain polyunsaturated fatty acids such as omega-3 (ω-3) have been widely investigated for their ability to alter behavior and the immune system [146]. ω-3 fatty acids can reduce microglial activation and the release of pro-inflammatory cytokines [146,147,148,149,150]. In addition to their effects on the immune system, supplementation of ω-3 fatty acids in adulthood can reduce anxiety-like and depression-like behaviors following adolescent LPS injections [151]. Consistent with the behavioral outcomes found in adulthood, early-life supplementation of ω-3 has been shown to prevent increases in anxiety-like and depression-like behavior following ELS [152,153]. Moreover, ω-3 fatty acid supplementation during gestation and early life has been shown to prevent alterations to the development of microglia in the HIP, while also reducing cognitive deficits following ELS [55,154].

2.2. Early-Life Stress and Microglia: Clinical Studies

Although the impact of ELS on microglia has been primarily investigated in a preclinical context, this aspect has rarely been studied in humans. The reason for this lies in the severe methodological limitations to the study of microglial morphology and functionality in the brains of living humans. Moreover, human postmortem brain studies have never investigated the long-term impact of ELS on microglia. Insights on this topic were offered by a recent PET study that used TSPO radioligand administration. In this study, PET scans were used to assay the relationship between childhood traumatic (abuse/neglect) experiences and central TSPO radioligand binding. The authors failed to identify significant differences in TSPO expression in the frontal, parietal, temporal, and occipital lobes when comparing healthy individuals with or without a history of exposure to psychosocial risk early in life [155]. This suggested that the exposure to ELS in humans did not induce a stable microglial activation. While this evidence contradicts the preclinical results, it could be due to several possible reasons. For example, in this study, only ELS individuals without a psychiatric diagnosis were recruited, suggesting that primarily “resilient” individuals were represented in the study, while the “ELS-vulnerable” population, with potentially more sensitive microglia, were excluded.
While TSPO radioligand administration is the only procedure that has been used to investigate the impact of ELS on microglia, other targets for PET studies may prove to be more valuable. For example, Horti et al. (2019) recently developed [11C]CPPC, a positron-emitting, high-affinity ligand that is specific to macrophage CSF1R, which is primarily restricted to microglia in the brain. [11C]CPPC demonstrates high and specific brain uptake in a murine and nonhuman primate LPS model of neuroinflammation. It also shows specific and elevated uptake in a murine model of Alzheimer’s disease and postmortem brain tissue of patients with the disease, suggesting that [11C]CPPC may represent a promising tool to target microglia in the human brain [156]. Although researchers are currently developing techniques to investigate microglial activity in humans, much more work is required to identify potential targets for future research and test whether existing methods are valid and reproducible.
In addition to the fact that there have been no studies to date identifying the role of microglia following ELS in clinical populations, there is no literature investigating the potential benefits of early interventions following ELS. There are several studies, however, that demonstrate the involvement of both ω-3 fatty acids and oxytocin in development. For example, higher levels of ω-3 fatty acids in maternal milk are associated with better temperament in children [157], and reduce negative affect and inflammation in children that have mothers with high levels of adiposity [158], while lower levels of oxytocin have been related to experiences of severe emotional neglect and abuse in childhood in plasma and cerebrospinal fluid samples [159,160]. Children raised in orphanages who experienced neglect have also been shown to have lower oxytocin plasma levels [161]. Additionally, mothers who reported experiencing childhood trauma had lower oxytocin plasma levels and engaged in less positive parenting styles [162]. Despite this evidence, it is not known if microglia are involved in these ω-3 fatty acid and oxytocin effects on children and whether this involvement is also observable in the presence of ELS.

2.3. Perspectives

The literature collected and described in this review shows that ELS has robust effects on microglial functionality and morphology, and that ELS-induced microglial activation mediates the emergence of brain and behavioral alterations. Interestingly, these effects strongly depend on the developmental timing of ELS application. This may be due to a diverse sensitivity of microglial and neuronal processes across development [2,163]. Indeed, during development, microglia undergo different stages of maturation (from brain colonization to acquisition of an adult phenotype) associated with specific functional roles [164]. In this review, we showed that ELS interferes with microglial developmental programs, including their proliferation and death as well as their phagocytic activity. This, in turn, can affect neuronal and non-neuronal developmental processes, which are dynamic during development [68,74] and for which microglial activity is instrumental. The effects of ELS on microglia also depend on the time point of investigation. This dependency may result from changes in local environmental cues associated with acute or delayed effects of the stress [165]. Indeed, microglia reactivity is determined by these cues [164,166]. Furthermore, we have presented evidence for a priming effect of both pre- and postnatal ELS on microglial reactivity, indicating a long-lasting alteration, which has been implicated in behavioral abnormalities later in life. In conjunction with these findings, sex-related differences in microglial responses to ELS and consequent behavioral outcomes have been found. However, studies using different ELS procedures have yielded different outcomes. As previously described by Bordt, Caesrine, and Bilbo (2019), sex differences in microglial number and morphology exist during critical periods of development [167]. These developmental differences may mediate the diverse sex-specific reactivity to ELS [168]. Further research is required to determine how these varying ELS models facilitate these differences.
Although the literature surrounding ELS and microglia has grown exponentially, there are several limitations within the existing body of work that still need to be addressed. First, many of these studies have focused on one or few target structures for investigation, particularly the HIP. As reviewed by Tan, Yuan, and Tian (2019), microglia show regional heterogeneity in density, morphology, and phenotype, which may underlie differential responsivity to stimuli, including stress and inflammatory conditions [69,169]. This spatial heterogeneity could be important for tuning neuronal/glial functions and neural circuitry, thus contributing to the region-specific effects of ELS on the brain. Recently, deep single-cell RNA sequencing (scRNAseq) data from isolated microglia cells has revealed several transcriptionally distinct clusters throughout each developmental stage [170,171,172]. Based on this evidence, Stratoulias and colleagues (2019) hypothesized that microglia constitute a heterogeneous population, in which each cell displays intrinsic properties and functional specializations regardless of the structure [173]. As a result, neighboring microglial cells may have different responses to the same stimulus. Therefore, further research is necessary to investigate how microglial subsets act in an ELS context. In addition, microglia have been analyzed phenotypically and functionally using cellular markers that are also expressed on central-nervous system-associated macrophages and peripheral innate immune cells. This is relevant in the context of ELS, due to the fact that ELS has been shown to induce BBB leakage [174]. With this increase in permeability, peripheral immune cells have been proposed to enter the brain [175]. Notably, these populations may bolster microglial diversity, as observed by a recent transcriptome study by Prinz and colleagues [176]. While the role of these immune cells in brain development following ELS has yet to be explored, it is possible that some of the outcomes associated with ELS may be facilitated via the actions of the peripheral immune system [177]. Moreover, rodent experiments have shown that peripheral inflammatory stimuli can affect microglia in the brain [178]. Using markers that target subpopulations of microglia and macrophages such as transmembrane protein 119 (TMEM119), P2Y purinoceptor 12 (P2RY12), and Sal-like protein 1 (SALL1) [10,179], it would be valuable to identify how various types of microglia and resident/peripheral macrophages relate to alterations in brain development and behavior following ELS.
There is still a gap of knowledge surrounding the mechanisms through which ELS impacts microglia, and how microglial modifications mediate ELS health-related outcomes. Both genetic and epigenetic factors are thought to play a role in the long-term effects of ELS [180]. Currently, no study has investigated the contribution of microglia to these factors in the context of ELS. Future bioinformatic analyses should explore whether genetic risk factors and/or epigenetic modifications associated with ELS health outcomes are related to microglia function and activity [181].
While research continues to implicate microglia as mediators in a host of psychopathologies, identifying preventive strategies to reduce the impact of ELS on microglia is of the utmost importance. In this review, we have presented several new measures that may prevent ELS impact on microglia. While these models show promise, further research is required to elucidate whether and how the considered measures can be used to prevent the effects of ELS on microglia and, consequently, on behavioral outcomes, particularly in the clinical setting.

3. Conclusions

Overall, preclinical research supports the hypothesis that ELS can exert its effects on brain and behavior through microglia-mediated processes. This evidence should be used to drive clinical research to verify and confirm the relevance of this phenomenon in humans. However, several limitations delay this research, including (1) the paucity of suitable radioligands for studying microglia by PET; (2) the difficulty of identifying the effects of specific ELS events on the brain, due to the fact that multiple stressful stimuli often co-occur during development, which distorts the original cause of an alteration; (3) evaluating the impact of pre- and postnatal stressful events on brain and behavior requires extensive and longitudinal studies where subjects should be monitored in terms of mental and physical health throughout development and into adulthood. Future efforts are required to investigate microglia in humans and, using novel techniques, understand how microglia relate to ELS and psychopathology.

Author Contributions

C.C., S.G., L.L.I. and V.C. wrote the manuscript; C.C. and V.C. designed figure and tables. All authors have read and agreed to the published version of the manuscript.

Funding

The APC was funded by Sapienza University of Rome, grant number RG11916B50652E41 to V.C.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Kessler, R.C.; McLaughlin, K.A.; Green, J.G.; Gruber, M.J.; Sampson, N.A.; Zaslavsky, A.M.; Aguilar-Gaxiola, S.; Alhamzawi, A.O.; Alonso, J.; Angermeyer, M. Childhood adversities and adult psychopathology in the WHO World Mental Health Surveys. Br. J. Psychiatry 2010, 197, 378–385. [Google Scholar] [CrossRef] [Green Version]
  2. Teicher, M.H.; Samson, J.A.; Anderson, C.M.; Ohashi, K. The effects of childhood maltreatment on brain structure, function, and connectivity. Nat. Rev. Neurosci. 2016, 17, 652–666. [Google Scholar] [CrossRef]
  3. Vaiserman, A.M.; Koliada, A.K. Early-life adversity and long-term neurobehavioral outcomes: Epigenome as a bridge? Hum. Genom. 2017, 11, 432–445. [Google Scholar] [CrossRef] [Green Version]
  4. Iacono, L.L.; Valzania, A.; Visco-Comandini, F.; Aricò, E.; Viscomi, M.T.; Castiello, L.; Oddi, D.; D’Amato, F.R.; Bisicchia, E.; Ermakova, O.; et al. Social threat exposure in juvenile mice promotes cocaine-seeking by altering blood clotting and brain vasculature. Addict. Biol. 2017, 22, 911–922. [Google Scholar] [CrossRef]
  5. Blaisdell, K.N.; Imhof, A.M.; Fisher, P.A. Early adversity, child neglect, and stress neurobiology: From observations of impact to empirical evaluations of mechanisms. Int. J. Dev. Neurosci. 2019, 78, 139–146. [Google Scholar] [CrossRef]
  6. Agorastos, A.; Pervanidou, P.; Chrousos, G.P.; Baker, D.G. Developmental Trajectories of Early Life Stress and Trauma: A Narrative Review on Neurobiological Aspects Beyond Stress System Dysregulation. Front. Psychiatry 2019, 10, 118. [Google Scholar] [CrossRef] [Green Version]
  7. Johnson, F.K.; Kaffman, A. Early life stress perturbs the function of microglia in the developing rodent brain: New insights and future challenges. Brain Behav. Immun. 2018, 69, 18–27. [Google Scholar] [CrossRef]
  8. Ransohoff, R.M.; Cardona, A.E. The myeloid cells of the central nervous system parenchyma. Nature 2010, 468, 253–262. [Google Scholar] [CrossRef]
  9. Schafer, D.P.; Stevens, B. Microglia Function in Central Nervous System Development and Plasticity. Cold Spring Harb. Perspect. Biol. 2015, 7, a020545. [Google Scholar] [CrossRef]
  10. Li, Q.; Barres, B.A. Microglia and macrophages in brain homeostasis and disease. Nat. Rev. Immunol. 2018, 18, 225–242. [Google Scholar] [CrossRef]
  11. Thion, M.S.; Ginhoux, F.; Garel, S. Microglia and early brain development: An intimate journey. Science 2018, 362, 185–189. [Google Scholar] [CrossRef] [Green Version]
  12. Kopec, A.M.; Smith, C.J.; Ayre, N.R.; Sweat, S.C.; Bilbo, S.D. Microglial dopamine receptor elimination defines sex-specific nucleus accumbens development and social behavior in adolescent rats. Nat. Commun. 2018, 9, 1–16. [Google Scholar] [CrossRef] [Green Version]
  13. Cowan, M.; Petri, W.A. Microglia: Immune Regulators of Neurodevelopment. Front. Immunol. 2018, 9, 2576. [Google Scholar] [CrossRef] [Green Version]
  14. Wright-Jin, E.C.; Gutmann, D.H. Microglia as Dynamic Cellular Mediators of Brain Function. Trends Mol. Med. 2019, 25, 967–979. [Google Scholar] [CrossRef]
  15. Frank, M.G.; Fonken, L.K.; Watkins, L.R.; Maier, S.F. Microglia: Neuroimmune-sensors of stress. Semin. Cell Dev. Biol. 2019, 94, 176–185. [Google Scholar] [CrossRef]
  16. Wolf, S.A.; Boddeke, H.W.G.M.; Kettenmann, H. Microglia in Physiology and Disease. Annu. Rev. Physiol. 2017, 79, 619–643. [Google Scholar] [CrossRef]
  17. Paolicelli, R.C.; Ferretti, M.T. Function and Dysfunction of Microglia during Brain Development: Consequences for Synapses and Neural Circuits. Front. Synaptic Neurosci. 2017, 9, 9. [Google Scholar] [CrossRef]
  18. Burke, N.N.; Fan, C.Y.; Trang, T. Microglia in health and pain: Impact of noxious early life events. Exp. Physiol. 2016, 101, 1003–1021. [Google Scholar] [CrossRef] [Green Version]
  19. Harry, G.J. Microglia During Development and Aging. Pharmacol. Ther. 2013, 139, 313–326. [Google Scholar] [CrossRef] [Green Version]
  20. Wu, Y.; Dissing-Olesen, L.; MacVicar, B.A.; Stevens, B. Microglia: Dynamic Mediators of Synapse Development and Plasticity. Trends Immunol. 2015, 36, 605–613. [Google Scholar] [CrossRef]
  21. York, E.M.; Bernier, L.-P.; MacVicar, B.A. Microglial modulation of neuronal activity in the healthy brain. Dev. Neurobiol. 2018, 78, 593–603. [Google Scholar] [CrossRef] [PubMed]
  22. Marinelli, S.; Basilico, B.; Marrone, M.C.; Ragozzino, D. Microglia-neuron crosstalk: Signaling mechanism and control of synaptic transmission. Semin. Cell Dev. Biol. 2019, 94, 138–151. [Google Scholar] [CrossRef] [PubMed]
  23. Fan, R.; Xu, F.; Previti, M.L.; Davis, J.; Grande, A.M.; Robinson, J.K.; Van Nostrand, W.E. Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid. J. Neurosci. 2007, 27, 3057–3063. [Google Scholar] [CrossRef] [Green Version]
  24. Hayakawa, K.; Mishima, K.; Nozako, M.; Hazekawa, M.; Mishima, S.; Fujioka, M.; Orito, K.; Egashira, N.; Iwasaki, K.; Fujiwara, M. Delayed treatment with minocycline ameliorates neurologic impairment through activated microglia expressing a high-mobility group box1-inhibiting mechanism. Stroke 2008, 39, 951–958. [Google Scholar] [CrossRef] [Green Version]
  25. Mishra, M.K.; Basu, A. Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis. J. Neurochem. 2008, 105, 1582–1595. [Google Scholar] [CrossRef]
  26. Chen, M.-K.; Guilarte, T.R. Translocator protein 18 kDa (TSPO): Molecular sensor of brain injury and repair. Pharmacol. Ther. 2008, 118, 1–17. [Google Scholar] [CrossRef]
  27. Rupprecht, R.; Papadopoulos, V.; Rammes, G.; Baghai, T.C.; Fan, J.; Akula, N.; Groyer, G.; Adams, D.; Schumacher, M. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat. Rev. Drug Discov. 2010, 9, 971–988. [Google Scholar] [CrossRef]
  28. Gómez-González, B.; Escobar, A. Prenatal stress alters microglial development and distribution in postnatal rat brain. Acta Neuropathol. 2010, 119, 303–315. [Google Scholar] [CrossRef]
  29. Zhao, Q.; Peng, C.; Wu, X.; Chen, Y.; Wang, C.; You, Z. Maternal sleep deprivation inhibits hippocampal neurogenesis associated with inflammatory response in young offspring rats. Neurobiol. Dis. 2014, 68, 57–65. [Google Scholar] [CrossRef]
  30. Zhao, Q.; Xie, X.; Fan, Y.; Zhang, J.; Jiang, W.; Wu, X.; Yan, S.; Chen, Y.; Peng, C.; You, Z. Phenotypic dysregulation of microglial activation in young offspring rats with maternal sleep deprivation-induced cognitive impairment. Sci. Rep. 2015, 5, 9513. [Google Scholar] [CrossRef] [Green Version]
  31. Diz-Chaves, Y.; Astiz, M.; Bellini, M.J.; Garcia-Segura, L.M. Prenatal stress increases the expression of proinflammatory cytokines and exacerbates the inflammatory response to LPS in the hippocampal formation of adult male mice. Brain Behav. Immun. 2013, 28, 196–206. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Estes, M.L.; McAllister, A.K. Maternal immune activation: Implications for neuropsychiatric disorders. Science 2016, 353, 772–777. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Smolders, S.; Notter, T.; Smolders, S.M.T.; Rigo, J.-M.; Brône, B. Controversies and prospects about microglia in maternal immune activation models for neurodevelopmental disorders. Brain Behav. Immun. 2018, 73, 51–65. [Google Scholar] [CrossRef] [PubMed]
  34. Mattei, D.; Djodari-Irani, A.; Hadar, R.; Pelz, A.; de Cossío, L.F.; Goetz, T.; Matyash, M.; Kettenmann, H.; Winter, C.; Wolf, S.A. Minocycline rescues decrease in neurogenesis, increase in microglia cytokines and deficits in sensorimotor gating in an animal model of schizophrenia. Brain Behav. Immun. 2014, 38, 175–184. [Google Scholar] [CrossRef] [Green Version]
  35. Van den Eynde, K.; Missault, S.; Fransen, E.; Raeymaekers, L.; Willems, R.; Drinkenburg, W.; Timmermans, J.-P.; Kumar-Singh, S.; Dedeurwaerdere, S. Hypolocomotive behaviour associated with increased microglia in a prenatal immune activation model with relevance to schizophrenia. Behav. Brain Res. 2014, 258, 179–186. [Google Scholar] [CrossRef]
  36. Zhu, F.; Zheng, Y.; Liu, Y.; Zhang, X.; Zhao, J. Minocycline alleviates behavioral deficits and inhibits microglial activation in the offspring of pregnant mice after administration of polyriboinosinic–polyribocytidilic acid. Psychiatry Res. 2014, 219, 680–686. [Google Scholar] [CrossRef]
  37. Giovanoli, S.; Engler, H.; Engler, A.; Richetto, J.; Feldon, J.; Riva, M.A.; Schedlowski, M.; Meyer, U. Preventive effects of minocycline in a neurodevelopmental two-hit model with relevance to schizophrenia. Transl. Psychiatry 2016, 6, 772. [Google Scholar] [CrossRef] [Green Version]
  38. Fernández de Cossío, L.; Guzmán, A.; van der Veldt, S.; Luheshi, G.N. Prenatal infection leads to ASD-like behavior and altered synaptic pruning in the mouse offspring. Brain Behav. Immun. 2017, 63, 88–98. [Google Scholar] [CrossRef]
  39. Hui, C.W.; St-Pierre, A.; El Hajj, H.; Remy, Y.; Hébert, S.S.; Luheshi, G.N.; Srivastava, L.K.; Tremblay, M.-È. Prenatal Immune Challenge in Mice Leads to Partly Sex-Dependent Behavioral, Microglial, and Molecular Abnormalities Associated with Schizophrenia. Front. Mol. Neurosci. 2018, 11, 673–681. [Google Scholar] [CrossRef] [Green Version]
  40. Thion, M.S.; Mosser, C.-A.; Férézou, I.; Grisel, P.; Baptista, S.; Low, D.; Ginhoux, F.; Garel, S.; Audinat, E. Biphasic Impact of Prenatal Inflammation and Macrophage Depletion on the Wiring of Neocortical Inhibitory Circuits. Cell Rep. 2019, 28, 1119–1126. [Google Scholar] [CrossRef] [Green Version]
  41. Giovanoli, S.; Engler, H.; Engler, A.; Richetto, J.; Voget, M.; Willi, R.; Winter, C.; Riva, M.A.; Mortensen, P.B.; Feldon, J.; et al. Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science 2013, 339, 1095–1099. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Sherman, M.P.; Zaghouani, H.; Niklas, V. Gut microbiota, the immune system, and diet influence the neonatal gut-brain axis. Pediatr. Res. 2015, 77, 127–135. [Google Scholar] [CrossRef] [PubMed]
  43. Cohen, S.; Ke, X.; Liu, Q.; Fu, Q.; Majnik, A.; Lane, R. Adverse early life environment increases hippocampal microglia abundance in conjunction with decreased neural stem cells in juvenile mice. Int. J. Dev. Neurosci. 2016, 55, 56–65. [Google Scholar] [CrossRef] [PubMed]
  44. Edlow, A.G.; Glass, R.M.; Smith, C.J.; Tran, P.K.; James, K.; Bilbo, S. Placental Macrophages: A Window Into Fetal Microglial Function in Maternal Obesity. Int. J. Dev. Neurosci. 2019, 77, 60–68. [Google Scholar] [CrossRef] [PubMed]
  45. Mairesse, J.; Zinni, M.; Pansiot, J.; Hassan-Abdi, R.; Demene, C.; Colella, M.; Charriaut-Marlangue, C.; Rideau Batista Novais, A.; Tanter, M.; Maccari, S.; et al. Oxytocin receptor agonist reduces perinatal brain damage by targeting microglia. Glia 2019, 67, 345–359. [Google Scholar] [CrossRef] [PubMed]
  46. Komada, M.; Hara, N.; Kawachi, S.; Kawachi, K.; Kagawa, N.; Nagao, T.; Ikeda, Y. Mechanisms underlying neuro-inflammation and neurodevelopmental toxicity in the mouse neocortex following prenatal exposure to ethanol. Sci. Rep. 2017, 7, 234–257. [Google Scholar] [CrossRef] [Green Version]
  47. Bolton, J.L.; Auten, R.L.; Bilbo, S.D. Prenatal air pollution exposure induces sexually dimorphic fetal programming of metabolic and neuroinflammatory outcomes in adult offspring. Brain Behav. Immun. 2014, 37, 30–44. [Google Scholar] [CrossRef]
  48. Bolton, J.L.; Marinero, S.; Hassanzadeh, T.; Natesan, D.; Le, D.; Belliveau, C.; Mason, S.N.; Auten, R.L.; Bilbo, S.D. Gestational Exposure to Air Pollution Alters Cortical Volume, Microglial Morphology, and Microglia-Neuron Interactions in a Sex-Specific Manner. Front. Synaptic Neurosci. 2017, 9, 672–695. [Google Scholar] [CrossRef] [Green Version]
  49. Matcovitch-Natan, O.; Winter, D.R.; Giladi, A.; Vargas Aguilar, S.; Spinrad, A.; Sarrazin, S.; Ben-Yehuda, H.; David, E.; Zelada González, F.; Perrin, P.; et al. Microglia development follows a stepwise program to regulate brain homeostasis. Science 2016, 353, 8670. [Google Scholar] [CrossRef]
  50. Mattei, D.; Ivanov, A.; Ferrai, C.; Jordan, P.; Guneykaya, D.; Buonfiglioli, A.; Schaafsma, W.; Przanowski, P.; Deuther-Conrad, W.; Brust, P.; et al. Maternal immune activation results in complex microglial transcriptome signature in the adult offspring that is reversed by minocycline treatment. Transl. Psychiatry 2017, 7, 1120. [Google Scholar] [CrossRef]
  51. Field, E.J. Observations on the development of microglia together with a note on the influence of cortisone. J. Anat. 1955, 89, 201–208. [Google Scholar] [PubMed]
  52. Ling, E.A.; Kaur, C.; Wong, W.C. Light and electron microscopic demonstration of non-specific esterase in amoeboid microglial cells in the corpus callosum in postnatal rats: A cytochemical link to monocytes. J. Anat. 1982, 135, 385–394. [Google Scholar] [PubMed]
  53. Kaur, C.; Wu, C.H.; Wen, C.Y.; Ling, E.A. The Effects of Subcutaneous Injections of Glucocorticoids on Amoeboid Microglia in Postnatal Rats. Arch. Histol. Cytol. 1994, 57, 449–459. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Wu, C.H.; Chien, H.F.; Chang, C.Y.; Chen, S.H.; Huang, Y.S. Response of amoeboid and differentiating ramified microglia to glucocorticoids in postnatal rats: A lectin histochemical and ultrastructural study. Neurosci. Res. 2001, 40, 235–244. [Google Scholar] [CrossRef]
  55. Yam, K.-Y.; Schipper, L.; Reemst, K.; Ruigrok, S.R.; Abbink, M.R.; Hoeijmakers, L.; Naninck, E.F.G.; Zarekiani, P.; Oosting, A.; Van der Beek, E.M.; et al. Increasing availability of ω-3 fatty acid in the early-life diet prevents the early-life stress-induced cognitive impairments without affecting metabolic alterations. FASEB J. 2019, 33, 5729–5740. [Google Scholar] [CrossRef]
  56. Hoeijmakers, L.; Ruigrok, S.R.; Amelianchik, A.; Ivan, D.; van Dam, A.-M.; Lucassen, P.J.; Korosi, A. Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer’s disease mouse model. Brain Behav. Immun. 2017, 63, 160–175. [Google Scholar] [CrossRef]
  57. Roque, A.; Ochoa-Zarzosa, A.; Torner, L. Maternal separation activates microglial cells and induces an inflammatory response in the hippocampus of male rat pups, independently of hypothalamic and peripheral cytokine levels. Brain Behav. Immun. 2016, 55, 39–48. [Google Scholar] [CrossRef]
  58. Delpech, J.-C.; Wei, L.; Hao, J.; Yu, X.; Madore, C.; Butovsky, O.; Kaffman, A. Early life stress perturbs the maturation of microglia in the developing hippocampus. Brain Behav. Immun. 2016, 57, 79–93. [Google Scholar] [CrossRef] [Green Version]
  59. Saavedra, L.M.; Fenton Navarro, B.; Torner, L. Early Life Stress Activates Glial Cells in the Hippocampus but Attenuates Cytokine Secretion in Response to an Immune Challenge in Rat Pups. Neuroimmunomodulation 2017, 24, 242–255. [Google Scholar] [CrossRef]
  60. Baldy, C.; Fournier, S.; Boisjoly-Villeneuve, S.; Tremblay, M.-È.; Kinkead, R. The influence of sex and neonatal stress on medullary microglia in rat pups. Exp. Physiol. 2018, 103, 1192–1199. [Google Scholar] [CrossRef]
  61. Réus, G.Z.; Silva, R.H.; de Moura, A.B.; Presa, J.F.; Abelaira, H.M.; Abatti, M.; Vieira, A.; Pescador, B.; Michels, M.; Ignácio, Z.M.; et al. Early Maternal Deprivation Induces Microglial Activation, Alters Glial Fibrillary Acidic Protein Immunoreactivity and Indoleamine 2,3-Dioxygenase during the Development of Offspring Rats. Mol. Neurobiol. 2019, 56, 1096–1108. [Google Scholar] [CrossRef] [PubMed]
  62. Chocyk, A.; Dudys, D.; Przyborowska, A.; Majcher, I.; Maćkowiak, M.; Wędzony, K. Maternal separation affects the number, proliferation and apoptosis of glia cells in the substantia nigra and ventral tegmental area of juvenile rats. Neuroscience 2011, 173, 1–18. [Google Scholar] [CrossRef] [PubMed]
  63. Banqueri, M.; Méndez, M.; Gómez-Lázaro, E.; Arias, J.L. Early life stress by repeated maternal separation induces long-term neuroinflammatory response in glial cells of male rats. Stress 2019, 22, 563–570. [Google Scholar] [CrossRef] [PubMed]
  64. Genty, J.; Tetsi Nomigni, M.; Anton, F.; Hanesch, U. Maternal separation stress leads to resilience against neuropathic pain in adulthood. Neurobiol. Stress 2018, 8, 21–32. [Google Scholar] [CrossRef]
  65. Takatsuru, Y.; Nabekura, J.; Ishikawa, T.; Kohsaka, S.; Koibuchi, N. Early-life stress increases the motility of microglia in adulthood. J. Physiol. Sci. 2015, 65, 187–194. [Google Scholar] [CrossRef]
  66. Gong, Y.; Tong, L.; Yang, R.; Hu, W.; Xu, X.; Wang, W.; Wang, P.; Lu, X.; Gao, M.; Wu, Y.; et al. Dynamic changes in hippocampal microglia contribute to depressive-like behavior induced by early social isolation. Neuropharmacology 2018, 135, 223–233. [Google Scholar] [CrossRef]
  67. Zhang, Y.; Xu, H.; Wang, J.; Ren, F.; Shao, F.; Ellenbroek, B.; Lin, W.; Wang, W. Transient upregulation of immune activity induced by adolescent social stress is involved in cognitive deficit in adult male mice and early intervention with minocycline. Behav. Brain Res. 2019, 374, 112–136. [Google Scholar] [CrossRef]
  68. Zhang, Y.; Xu, H.; Zhang, F.; Shao, F.; Ellenbroek, B.; Wang, J.; Wang, W. Deficiencies of microglia and TNFα in the mPFC-mediated cognitive inflexibility induced by social stress during adolescence. Brain Behav. Immun. 2019, 79, 256–266. [Google Scholar] [CrossRef]
  69. Lo Iacono, L.; Catale, C.; Martini, A.; Valzania, A.; Viscomi, M.T.; Chiurchiù, V.; Guatteo, E.; Bussone, S.; Perrone, F.; Di Sabato, P.; et al. From Traumatic Childhood to Cocaine Abuse: The Critical Function of the Immune System. Biol. Psychiatry 2018, 84, 905–916. [Google Scholar] [CrossRef] [Green Version]
  70. McCormick, C.M.; Thomas, C.M.; Sheridan, C.S.; Nixon, F.; Flynn, J.A.; Mathews, I.Z. Social instability stress in adolescent male rats alters hippocampal neurogenesis and produces deficits in spatial location memory in adulthood. Hippocampus 2012, 22, 1300–1312. [Google Scholar] [CrossRef]
  71. Han, Y.; Zhang, L.; Wang, Q.; Zhang, D.; Zhao, Q.; Zhang, J.; Xie, L.; Liu, G.; You, Z. Minocycline inhibits microglial activation and alleviates depressive-like behaviors in male adolescent mice subjected to maternal separation. Psychoneuroendocrinology 2019, 107, 37–45. [Google Scholar] [CrossRef] [PubMed]
  72. Ye, Y.; Yao, S.; Wang, R.; Fang, Z.; Zhong, K.; Nie, L.; Zhang, Q. PI3K/Akt/NF-κB signaling pathway regulates behaviors in adolescent female rats following with neonatal maternal deprivation and chronic mild stress. Behav. Brain Res. 2019, 362, 199–207. [Google Scholar] [CrossRef] [PubMed]
  73. Ganguly, P.; Thompson, V.; Gildawie, K.; Brenhouse, H.C. Adolescent food restriction in rats alters prefrontal cortex microglia in an experience-dependent manner. Stress 2018, 21, 162–168. [Google Scholar] [CrossRef]
  74. Wang, H.-T.; Huang, F.-L.; Hu, Z.-L.; Zhang, W.-J.; Qiao, X.-Q.; Huang, Y.-Q.; Dai, R.-P.; Li, F.; Li, C.Q. Early-Life Social Isolation-Induced Depressive-Like Behavior in Rats Results in Microglial Activation and Neuronal Histone Methylation that Are Mitigated by Minocycline. Neurotox. Res. 2017, 31, 505–520. [Google Scholar] [CrossRef] [PubMed]
  75. Schwarz, J.M.; Hutchinson, M.R.; Bilbo, S.D. Early-life experience decreases drug-induced reinstatement of morphine CPP in adulthood via microglial-specific epigenetic programming of anti-inflammatory IL-10 expression. J. Neurosci. 2011, 31, 17835–17847. [Google Scholar] [CrossRef] [PubMed]
  76. Tuan, L.-H.; Lee, L.-J. Microglia-mediated synaptic pruning is impaired in sleep-deprived adolescent mice. Neurobiol. Dis. 2019, 130, 104517. [Google Scholar] [CrossRef] [PubMed]
  77. Ahmad, A.; Shah, S.A.; Badshah, H.; Kim, M.J.; Ali, T.; Yoon, G.H.; Kim, T.H.; Abid, N.B.; Rehman, S.U.; Khan, S.; et al. Neuroprotection by Vitamin C Against Ethanol-Induced Neuroinflammation Associated Neurodegeneration in the Developing Rat Brain. CNS Neurol. Disord. Drug Targets Former. Curr. Drug Targets-CNS Neurol. Disord. 2016, 15, 360–370. [Google Scholar] [CrossRef] [PubMed]
  78. Chastain, L.G.; Franklin, T.; Gangisetty, O.; Cabrera, M.A.; Mukherjee, S.; Shrivastava, P.; Jabbar, S.; Sarkar, D.K. Early life alcohol exposure primes hypothalamic microglia to later-life hypersensitivity to immune stress: Possible epigenetic mechanism. Neuropsychopharmacology 2019, 44, 1579–1588. [Google Scholar] [CrossRef]
  79. Boschen, K.E.; Ruggiero, M.J.; Klintsova, A.Y. Neonatal binge alcohol exposure increases microglial activation in the developing rat hippocampus. Neuroscience 2016, 324, 355–366. [Google Scholar] [CrossRef] [Green Version]
  80. Ji, Z.; Yuan, L.; Lu, X.; Ding, H.; Luo, J.; Ke, Z.-J. Binge Alcohol Exposure Causes Neurobehavioral Deficits and GSK3β Activation in the Hippocampus of Adolescent Rats. Sci. Rep. 2018, 8, 540–561. [Google Scholar] [CrossRef] [Green Version]
  81. Ward, R.J.; Colivicchi, M.A.; Allen, R.; Schol, F.; Lallemand, F.; de Witte, P.; Ballini, C.; Corte, L.D.; Dexter, D. Neuro-inflammation induced in the hippocampus of “binge drinking” rats may be mediated by elevated extracellular glutamate content. J. Neurochem. 2009, 111, 1119–1128. [Google Scholar] [CrossRef] [PubMed]
  82. Topper, L.A.; Baculis, B.C.; Valenzuela, C.F. Exposure of neonatal rats to alcohol has differential effects on neuroinflammation and neuronal survival in the cerebellum and hippocampus. J. Neuroinflamm. 2015, 12, 160. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  83. McClain, J.A.; Morris, S.A.; Deeny, M.A.; Marshall, S.A.; Hayes, D.M.; Kiser, Z.M.; Nixon, K. Adolescent binge alcohol exposure induces long-lasting partial activation of microglia. Brain Behav. Immun. 2011, 25, S120–S128. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  84. Drew, P.D.; Johnson, J.W.; Douglas, J.C.; Phelan, K.D.; Kane, C.J.M. Pioglitazone Blocks Ethanol Induction of Microglial Activation and Immune Responses in the Hippocampus, Cerebellum, and Cerebral Cortex in a Mouse Model of Fetal Alcohol Spectrum Disorders. Alcohol. Clin. Exp. Res. 2015, 39, 445. [Google Scholar] [CrossRef] [Green Version]
  85. Kane, C.J.M.; Phelan, K.D.; Han, L.; Smith, R.R.; Xie, J.; Douglas, J.C.; Drew, P.D. Protection of neurons and microglia against ethanol in a mouse model of fetal alcohol spectrum disorders by peroxisome proliferator-activated receptor-γ agonists. Brain Behav. Immun. 2011, 25, S137–S145. [Google Scholar] [CrossRef] [Green Version]
  86. Ruggiero, M.J.; Boschen, K.E.; Roth, T.L.; Klintsova, A.Y. Sex Differences in Early Postnatal Microglial Colonization of the Developing Rat Hippocampus Following a Single-Day Alcohol Exposure. J. Neuroimmune Pharmacol. 2018, 13, 189–203. [Google Scholar] [CrossRef]
  87. Teixeira, F.B.; Santana, L.N.S.; Bezerra, F.R.; De Carvalho, S.; Fontes-Júnior, E.A.; Prediger, R.D.; Crespo-López, M.E.; Maia, C.S.F.; Lima, R.R. Chronic ethanol exposure during adolescence in rats induces motor impairments and cerebral cortex damage associated with oxidative stress. PLoS ONE 2014, 9, 105–113. [Google Scholar] [CrossRef] [Green Version]
  88. Ahlers, K.E.; Karaçay, B.; Fuller, L.; Bonthius, D.J.; Dailey, M.E. Transient activation of microglia following acute alcohol exposure in developing mouse neocortex is primarily driven by BAX-dependent neurodegeneration. Glia 2015, 63, 1694–1713. [Google Scholar] [CrossRef]
  89. Wong, E.L.; Lutz, N.M.; Hogan, V.A.; Lamantia, C.E.; McMurray, H.R.; Myers, J.R.; Ashton, J.M.; Majewska, A.K. Developmental alcohol exposure impairs synaptic plasticity without overtly altering microglial function in mouse visual cortex. Brain Behav. Immun. 2018, 67, 257–278. [Google Scholar] [CrossRef]
  90. Vetreno, R.P.; Crews, F.T. Adolescent binge drinking increases expression of the danger signal receptor agonist HMGB1 and toll-like receptors in the adult prefrontal cortex. Neuroscience 2012, 226, 475–488. [Google Scholar] [CrossRef] [Green Version]
  91. Schwarz, J.M.; Bilbo, S.D. Adolescent morphine exposure affects long-term microglial function and later-life relapse liability in a model of addiction. J. Neurosci. 2013, 33, 961–971. [Google Scholar] [CrossRef] [PubMed]
  92. Cardis, R.; Cabungcal, J.-H.; Dwir, D.; Do, K.Q.; Steullet, P. A lack of GluN2A-containing NMDA receptors confers a vulnerability to redox dysregulation: Consequences on parvalbumin interneurons, and their perineuronal nets. Neurobiol. Dis. 2018, 109, 64–75. [Google Scholar] [CrossRef]
  93. Wang, C.-Y.; Cheng, C.-W.; Wang, W.-H.; Chen, P.-S.; Tzeng, S.-F. Postnatal Stress Induced by Injection with Valproate Leads to Developing Emotional Disorders Along with Molecular and Cellular Changes in the Hippocampus and Amygdala. Mol. Neurobiol. 2016, 53, 6774–6785. [Google Scholar] [CrossRef] [PubMed]
  94. Coelho-Santos, V.; Cardoso, F.L.; Leitão, R.A.; Fontes-Ribeiro, C.A.; Silva, A.P. Impact of developmental exposure to methylphenidate on rat brain’s immune privilege and behavior: Control versus ADHD model. Brain Behav. Immun. 2018, 68, 169–182. [Google Scholar] [CrossRef] [PubMed]
  95. Moreno, J.A.; Streifel, K.M.; Sullivan, K.A.; Legare, M.E.; Tjalkens, R.B. Developmental exposure to manganese increases adult susceptibility to inflammatory activation of glia and neuronal protein nitration. Toxicol. Sci. 2009, 112, 405–415. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  96. Carias, E.; Hamilton, J.; Robison, L.S.; Delis, F.; Eiden, R.; Quattrin, T.; Hadjiargyrou, M.; Komatsu, D.; Thanos, P.K. Chronic oral methylphenidate treatment increases microglial activation in rats. J. Neural Transm. 2018, 125, 18671875. [Google Scholar] [CrossRef] [PubMed]
  97. Claypoole, L.D.; Zimmerberg, B.; Williamson, L.L. Neonatal lipopolysaccharide treatment alters hippocampal neuroinflammation, microglia morphology and anxiety-like behavior in rats selectively bred for an infantile trait. Brain Behav. Immun. 2017, 59, 135–146. [Google Scholar] [CrossRef]
  98. Tremblay, S.; Miloudi, K.; Chaychi, S.; Favret, S.; Binet, F.; Polosa, A.; Lachapelle, P.; Chemtob, S.; Sapieha, P. Systemic inflammation perturbs developmental retinal angiogenesis and neuroretinal function. Investig. Ophthalmol. Vis. Sci. 2013, 54, 8125–8139. [Google Scholar] [CrossRef] [Green Version]
  99. Pang, Y.; Dai, X.; Roller, A.; Carter, K.; Paul, I.; Bhatt, A.J.; Lin, R.C.S.; Fan, L.-W. Early Postnatal Lipopolysaccharide Exposure Leads to Enhanced Neurogenesis and Impaired Communicative Functions in Rats. PLoS ONE 2016, 11, 541–555. [Google Scholar] [CrossRef]
  100. Christensen, L.B.; Woods, T.A.; Carmody, A.B.; Caughey, B.; Peterson, K.E. Age-related differences in neuroinflammatory responses associated with a distinct profile of regulatory markers on neonatal microglia. J. Neuroinflamm. 2014, 11, 70. [Google Scholar] [CrossRef] [Green Version]
  101. Lei, Y.; Chen, C.-J.; Yan, X.-X.; Li, Z.; Deng, X.-H. Early-life lipopolysaccharide exposure potentiates forebrain expression of NLRP3 inflammasome proteins and anxiety-like behavior in adolescent rats. Brain Res. 2017, 1671, 43–54. [Google Scholar] [CrossRef] [PubMed]
  102. Berkiks, I.; Benmhammed, H.; Mesfioui, A.; Ouichou, A.; El Hasnaoui, A.; Mouden, S.; Touil, T.; Bahbiti, Y.; Nakache, R.; El Hessni, A. Postnatal melatonin treatment protects against affective disorders induced by early-life immune stimulation by reducing the microglia cell activation and oxidative stress. Int. J. Neurosci. 2018, 128, 495–504. [Google Scholar] [CrossRef] [PubMed]
  103. Sominsky, L.; Walker, A.K.; Ong, L.K.; Tynan, R.J.; Walker, F.R.; Hodgson, D.M. Increased microglial activation in the rat brain following neonatal exposure to a bacterial mimetic. Behav. Brain Res. 2012, 226, 351–356. [Google Scholar] [CrossRef] [PubMed]
  104. Wang, K.-C.; Fan, L.-W.; Kaizaki, A.; Pang, Y.; Cai, Z.; Tien, L.-T. Neonatal lipopolysaccharide exposure induces long-lasting learning impairment, less anxiety-like response and hippocampal injury in adult rats. Neuroscience 2013, 234, 146–157. [Google Scholar] [CrossRef] [Green Version]
  105. Fan, L.-W.; Tien, L.-T.; Zheng, B.; Pang, Y.; Lin, R.C.S.; Simpson, K.L.; Ma, T.; Rhodes, P.G.; Cai, Z. Dopaminergic neuronal injury in the adult rat brain following neonatal exposure to lipopolysaccharide and the silent neurotoxicity. Brain Behav. Immun. 2011, 25, 286–297. [Google Scholar] [CrossRef] [Green Version]
  106. Fan, L.-W.; Pang, Y.; Lin, S.; Tien, L.-T.; Ma, T.; Rhodes, P.G.; Cai, Z. Minocycline reduces lipopolysaccharide-induced neurological dysfunction and brain injury in the neonatal rat. J. Neurosci. Res. 2005, 82, 71–82. [Google Scholar] [CrossRef]
  107. Cardoso, F.L.; Herz, J.; Fernandes, A.; Rocha, J.; Sepodes, B.; Brito, M.A.; McGavern, D.B.; Brites, D. Systemic inflammation in early neonatal mice induces transient and lasting neurodegenerative effects. J. Neuroinflamm. 2015, 12, 82. [Google Scholar] [CrossRef] [Green Version]
  108. Bilbo, S.D.; Biedenkapp, J.C.; Der-Avakian, A.; Watkins, L.R.; Rudy, J.W.; Maier, S.F. Neonatal infection-induced memory impairment after lipopolysaccharide in adulthood is prevented via caspase-1 inhibition. J. Neurosci. 2005, 25, 8000–8009. [Google Scholar] [CrossRef] [Green Version]
  109. Bilbo, S.D.; Newsum, N.J.; Sprunger, D.B.; Watkins, L.R.; Rudy, J.W.; Maier, S.F. Differential effects of neonatal handling on early life infection-induced alterations in cognition in adulthood. Brain Behav. Immun. 2007, 21, 332–342. [Google Scholar] [CrossRef]
  110. Bland, S.T.; Beckley, J.T.; Young, S.; Tsang, V.; Watkins, L.R.; Maier, S.F.; Bilbo, S.D. Enduring consequences of early-life infection on glial and neural cell genesis within cognitive regions of the brain. Brain Behav. Immun. 2010, 24, 329–338. [Google Scholar] [CrossRef] [Green Version]
  111. Bland, S.T.; Beckley, J.T.; Watkins, L.R.; Maier, S.F.; Bilbo, S.D. Neonatal Escherichia coli infection alters glial, cytokine, and neuronal gene expression in response to acute amphetamine in adolescent rats. Neurosci. Lett. 2010, 474, 52–57. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  112. Williamson, L.L.; Sholar, P.W.; Mistry, R.S.; Smith, S.H.; Bilbo, S.D. Microglia and Memory: Modulation by Early-Life Infection. J. Neurosci. 2011, 31, 15511–15521. [Google Scholar] [CrossRef] [PubMed]
  113. Bussone, S.; Lo Iacono, L. The “systems approach” to treating the brain: Opportunities in developmental psychopharmacology. Dialogues Clin. Neurosci. 2019, 21, 211–215. [Google Scholar] [PubMed]
  114. Francis, D.D.; Diorio, J.; Plotsky, P.M.; Meaney, M.J. Environmental enrichment reverses the effects of maternal separation on stress reactivity. J. Neurosci. 2002, 22, 7840–7843. [Google Scholar] [CrossRef] [PubMed]
  115. Cui, M.; Yang, Y.; Yang, J.; Zhang, J.; Han, H.; Ma, W.; Li, H.; Mao, R.; Xu, L.; Hao, W.; et al. Enriched environment experience overcomes the memory deficits and depressive-like behavior induced by early life stress. Neurosci. Lett. 2006, 404, 208–212. [Google Scholar] [CrossRef]
  116. Hui, J.; Zhang, Z.; Liu, S.; Xi, G.; Zhang, X.; Teng, G.-J.; Chan, K.C.; Wu, E.X.; Nie, B.; Shan, B.; et al. Hippocampal neurochemistry is involved in the behavioural effects of neonatal maternal separation and their reversal by post-weaning environmental enrichment: A magnetic resonance study. Behav. Brain Res. 2011, 217, 122–127. [Google Scholar] [CrossRef]
  117. Vivinetto, A.L.; Suárez, M.M.; Rivarola, M.A. Neurobiological effects of neonatal maternal separation and post-weaning environmental enrichment. Behav. Brain Res. 2013, 240, 110–118. [Google Scholar] [CrossRef]
  118. Laviola, G.; Rea, M.; Morley-Fletcher, S.; Carlo, S.D.; Bacosi, A.; Simone, R.D.; Bertini, M.; Pacifici, R. Beneficial effects of enriched environment on adolescent rats from stressed pregnancies. Eur. J. Neurosci. 2004, 20, 1655–1664. [Google Scholar] [CrossRef]
  119. Prado, C.H.; Narahari, T.; Holland, F.H.; Lee, H.-N.; Murthy, S.K.; Brenhouse, H.C. Effects of early adolescent environmental enrichment on cognitive dysfunction, prefrontal cortex development, and inflammatory cytokines after early life stress. Dev. Psychobiol. 2016, 58, 482–491. [Google Scholar] [CrossRef]
  120. Ehninger, D.; Wang, L.-P.; Klempin, F.; Römer, B.; Kettenmann, H.; Kempermann, G. Enriched environment and physical activity reduce microglia and influence the fate of NG2 cells in the amygdala of adult mice. Cell Tissue Res. 2011, 345, 69–86. [Google Scholar] [CrossRef] [Green Version]
  121. Okuda, H.; Tatsumi, K.; Makinodan, M.; Yamauchi, T.; Kishimoto, T.; Wanaka, A. Environmental enrichment stimulates progenitor cell proliferation in the amygdala. J. Neurosci. Res. 2009, 87, 3546–3553. [Google Scholar] [CrossRef] [PubMed]
  122. Buschert, J.; Sakalem, M.E.; Saffari, R.; Hohoff, C.; Rothermundt, M.; Arolt, V.; Zhang, W.; Ambrée, O. Prenatal immune activation in mice blocks the effects of environmental enrichment on exploratory behavior and microglia density. Prog. Neuro Psychopharmacol. Biol. Psychiatry 2016, 67, 10–20. [Google Scholar] [CrossRef] [PubMed]
  123. Ehninger, D.; Kempermann, G. Regional Effects of Wheel Running and Environmental Enrichment on Cell Genesis and Microglia Proliferation in the Adult Murine Neocortex. Cereb. Cortex 2003, 13, 845–851. [Google Scholar] [CrossRef] [PubMed]
  124. Williamson, L.L.; Chao, A.; Bilbo, S.D. Environmental enrichment alters glial antigen expression and neuroimmune function in the adult rat hippocampus. Brain Behav. Immun. 2012, 26, 500–510. [Google Scholar] [CrossRef] [Green Version]
  125. Tsuda, M.C.; Yamaguchi, N.; Ogawa, S. Early life stress disrupts peripubertal development of aggression in male mice. Neuroreport 2011, 22, 259. [Google Scholar] [CrossRef]
  126. Myers, B.; Carvalho-Netto, E.; Wick-Carlson, D.; Wu, C.; Naser, S.; Solomon, M.B.; Ulrich-Lai, Y.M.; Herman, J.P. GABAergic Signaling within a Limbic-Hypothalamic Circuit Integrates Social and Anxiety-Like Behavior with Stress Reactivity. Neuropsychopharmacology 2016, 41, 1530–1539. [Google Scholar] [CrossRef] [Green Version]
  127. Yuan, L.; Liu, S.; Bai, X.; Gao, Y.; Liu, G.; Wang, X.; Liu, D.; Li, T.; Hao, A.; Wang, Z. Oxytocin inhibits lipopolysaccharide-induced inflammation in microglial cells and attenuates microglial activation in lipopolysaccharide-treated mice. J. Neuroinflamm. 2016, 13, 77. [Google Scholar] [CrossRef] [Green Version]
  128. Amini-Khoei, H.; Mohammadi-Asl, A.; Amiri, S.; Hosseini, M.-J.; Momeny, M.; Hassanipour, M.; Rastegar, M.; Haj-Mirzaian, A.; Mirzaian, A.H.-; Sanjarimoghaddam, H.; et al. Oxytocin mitigated the depressive-like behaviors of maternal separation stress through modulating mitochondrial function and neuroinflammation. Prog. Neuro Psychopharmacol. Biol. Psychiatry 2017, 76, 169–178. [Google Scholar] [CrossRef]
  129. Scott, L.J.; Goa, K.L. Galantamine: A review of its use in Alzheimer’s disease. Drugs 2000, 60, 1095–1122. [Google Scholar] [CrossRef]
  130. Guan, Y.-Z.; Jin, X.-D.; Guan, L.-X.; Yan, H.-C.; Wang, P.; Gong, Z.; Li, S.-J.; Cao, X.; Xing, Y.-L.; Gao, T.-M. Nicotine inhibits microglial proliferation and is neuroprotective in global ischemia rats. Mol. Neurobiol. 2015, 51, 1480–1488. [Google Scholar] [CrossRef]
  131. Furukawa, S.; Yang, L.; Sameshima, H. Galantamine, an acetylcholinesterase inhibitor, reduces brain damage induced by hypoxia-ischemia in newborn rats. Int. J. Dev. Neurosci. 2014, 37, 52–57. [Google Scholar] [CrossRef] [PubMed]
  132. Farlow, M.R. Clinical pharmacokinetics of galantamine. Clin. Pharmacokinet. 2003, 42, 1383–1392. [Google Scholar] [CrossRef] [PubMed]
  133. Giunta, B.; Ehrhart, J.; Townsend, K.; Sun, N.; Vendrame, M.; Shytle, D.; Tan, J.; Fernandez, F. Galantamine and nicotine have a synergistic effect on inhibition of microglial activation induced by HIV-1 gp120. Brain Res. Bull. 2004, 64, 165–170. [Google Scholar] [CrossRef] [PubMed]
  134. Benetti, F.; Mello, P.B.; Bonini, J.S.; Monteiro, S.; Cammarota, M.; Izquierdo, I. Early postnatal maternal deprivation in rats induces memory deficits in adult life that can be reversed by donepezil and galantamine. Int. J. Dev. Neurosci. 2009, 27, 59–64. [Google Scholar] [CrossRef] [PubMed]
  135. Takata, K.; Kitamura, Y.; Saeki, M.; Terada, M.; Kagitani, S.; Kitamura, R.; Fujikawa, Y.; Maelicke, A.; Tomimoto, H.; Taniguchi, T.; et al. Galantamine-induced Amyloid-β Clearance Mediated via Stimulation of Microglial Nicotinic Acetylcholine Receptors. J. Biol. Chem. 2010, 285, 40180–40191. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  136. Alexander, K.S.; Pocivavsek, A.; Wu, H.-Q.; Pershing, M.L.; Schwarcz, R.; Bruno, J.P. Early Developmental Elevations of Brain Kynurenic Acid Impair Cognitive Flexibility in Adults: Reversal with Galantamine. Neuroscience 2013, 238, 19–28. [Google Scholar] [CrossRef] [Green Version]
  137. Liu, Y.; Zhang, Y.; Zheng, X.; Fang, T.; Yang, X.; Luo, X.; Guo, A.; Newell, K.A.; Huang, X.-F.; Yu, Y. Galantamine improves cognition, hippocampal inflammation, and synaptic plasticity impairments induced by lipopolysaccharide in mice. J. Neuroinflamm. 2018, 15, 112. [Google Scholar] [CrossRef] [Green Version]
  138. Reiter, R.J. Pineal melatonin: Cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 1991, 12, 151–180. [Google Scholar] [CrossRef] [Green Version]
  139. Anderson, G.; Vaillancourt, C.; Maes, M.; Reiter, R.J. Breast Feeding and Melatonin: Implications For Improving Perinatal Health. J. Breastfeed. Biol. 2016, 1, 8. [Google Scholar] [CrossRef] [Green Version]
  140. Cao, S.; Shrestha, S.; Li, J.; Yu, X.; Chen, J.; Yan, F.; Ying, G.; Gu, C.; Wang, L.; Chen, G. Melatonin-mediated mitophagy protects against early brain injury after subarachnoid hemorrhage through inhibition of NLRP3 inflammasome activation. Sci. Rep. 2017, 7, 1–11. [Google Scholar] [CrossRef] [Green Version]
  141. Park, S.; Lee, D.-E.; Jang, H.; Byeon, Y.; Kim, Y.-S.; Back, K. Melatonin-rich transgenic rice plants exhibit resistance to herbicide-induced oxidative stress. J. Pineal Res. 2013, 54, 258–263. [Google Scholar] [CrossRef] [PubMed]
  142. Arioz, B.I.; Tastan, B.; Tarakcioglu, E.; Tufekci, K.U.; Olcum, M.; Ersoy, N.; Bagriyanik, A.; Genc, K.; Genc, S. Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway. Front. Immunol. 2019, 10, 476–481. [Google Scholar] [CrossRef] [PubMed]
  143. Hu, L.; Zhang, S.; Wen, H.; Liu, T.; Cai, J.; Du, D.; Zhu, D.; Chen, F.; Xia, C. Melatonin decreases M1 polarization via attenuating mitochondrial oxidative damage depending on UCP2 pathway in prorenin-treated microglia. PLoS ONE 2019, 14, 653–754. [Google Scholar] [CrossRef] [PubMed]
  144. Welin, A.-K.; Svedin, P.; Lapatto, R.; Sultan, B.; Hagberg, H.; Gressens, P.; Kjellmer, I.; Mallard, C. Melatonin Reduces Inflammation and Cell Death in White Matter in the Mid-Gestation Fetal Sheep Following Umbilical Cord Occlusion. Pediatr. Res. 2007, 61, 153–158. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  145. Chung, S.-Y.; Han, S.-H. Melatonin attenuates kainic acid-induced hippocampal neurodegeneration and oxidative stress through microglial inhibition. J. Pineal Res. 2003, 34, 95–102. [Google Scholar] [CrossRef] [PubMed]
  146. Larrieu, T.; Layé, S. Food for Mood: Relevance of Nutritional Omega-3 Fatty Acids for Depression and Anxiety. Front. Physiol. 2018, 9, 1047. [Google Scholar] [CrossRef]
  147. De Smedt-Peyrusse, V.; Sargueil, F.; Moranis, A.; Harizi, H.; Mongrand, S.; Layé, S. Docosahexaenoic acid prevents lipopolysaccharide-induced cytokine production in microglial cells by inhibiting lipopolysaccharide receptor presentation but not its membrane subdomain localization. J. Neurochem. 2008, 105, 296–307. [Google Scholar] [CrossRef]
  148. Pettit, L.K.; Varsanyi, C.; Tadros, J.; Vassiliou, E. Modulating the inflammatory properties of activated microglia with Docosahexaenoic acid and Aspirin. Lipids Health Dis. 2013, 12, 16. [Google Scholar] [CrossRef] [Green Version]
  149. Chang, J.P.-C.; Su, K.-P.; Mondelli, V.; Pariante, C.M. Omega-3 Polyunsaturated Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Clinical Trials and Biological Studies. Neuropsychopharmacology 2018, 43, 534–545. [Google Scholar] [CrossRef] [Green Version]
  150. Fourrier, C.; Remus-Borel, J.; Greenhalgh, A.D.; Guichardant, M.; Bernoud-Hubac, N.; Lagarde, M.; Joffre, C.; Layé, S. Docosahexaenoic acid-containing choline phospholipid modulates LPS-induced neuroinflammation in vivo and in microglia in vitro. J. Neuroinflamm. 2017, 14, 170. [Google Scholar] [CrossRef]
  151. Dang, R.; Zhou, X.; Xu, P.; Guo, Y.; Gong, X.; Wang, S.; Yuan, F.; Yao, J.; Jiang, P. ω-3 polyunsaturated fatty acid supplementation ameliorates lipopolysaccharide-induced behavioral deficits and modulates neurotrophic factors in rats: Focus on tPA/PAI-1 system and BDNF-TrkB signaling. J. Funct. Food. 2017, 30, 74–80. [Google Scholar] [CrossRef]
  152. Ferraz, A.C.; Delattre, A.M.; Almendra, R.G.; Sonagli, M.; Borges, C.; Araujo, P.; Andersen, M.L.; Tufik, S.; Lima, M.M.S. Chronic ω-3 fatty acids supplementation promotes beneficial effects on anxiety, cognitive and depressive-like behaviors in rats subjected to a restraint stress protocol. Behav. Brain Res. 2011, 219, 116–122. [Google Scholar] [CrossRef] [PubMed]
  153. Réus, G.Z.; Maciel, A.L.; Abelaira, H.M.; de Moura, A.B.; de Souza, T.G.; Dos Santos, T.R.; Darabas, A.C.; Parzianello, M.; Matos, D.; Abatti, M.; et al. ω-3 and folic acid act against depressive-like behavior and oxidative damage in the brain of rats subjected to early- or late-life stress. Nutrition 2018, 53, 120–133. [Google Scholar] [CrossRef] [PubMed]
  154. Madore, C.; Nadjar, A.; Delpech, J.-C.; Sere, A.; Aubert, A.; Portal, C.; Joffre, C.; Layé, S. Nutritional n-3 PUFAs deficiency during perinatal periods alters brain innate immune system and neuronal plasticity-associated genes. Brain Behav. Immun. 2014, 41, 22–31. [Google Scholar] [CrossRef]
  155. Dahoun, T.; Calcia, M.A.; Veronese, M.; Bloomfield, P.; Reis Marques, T.; Turkheimer, F.; Howes, O.D. The association of psychosocial risk factors for mental health with a brain marker altered by inflammation: A translocator protein (TSPO) PET imaging study. Brain Behav. Immun. 2019, 80, 742–750. [Google Scholar] [CrossRef]
  156. Horti, A.G.; Naik, R.; Foss, C.A.; Minn, I.; Misheneva, V.; Du, Y.; Wang, Y.; Mathews, W.B.; Wu, Y.; Hall, A.; et al. PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R). Proc. Natl. Acad. Sci. USA 2019, 116, 1686–1691. [Google Scholar] [CrossRef] [Green Version]
  157. Hahn-Holbrook, J.; Fish, A.; Glynn, L.M. Human Milk Omega-3 Fatty Acid Composition is Associated with Infant Temperament. Nutrients 2019, 11, 2964. [Google Scholar] [CrossRef] [Green Version]
  158. Gustafsson, H.C.; Holton, K.F.; Anderson, A.N.; Nousen, E.K.; Sullivan, C.A.; Loftis, J.M.; Nigg, J.T.; Sullivan, E.L. Increased Maternal Prenatal Adiposity, Inflammation, and Lower Omega-3 Fatty Acid Levels Influence Child Negative Affect. Front. Neurosci. 2019, 13, 1035. [Google Scholar] [CrossRef]
  159. Jobst, A.; Padberg, F.; Mauer, M.-C.; Daltrozzo, T.; Bauriedl-Schmidt, C.; Sabass, L.; Sarubin, N.; Falkai, P.; Renneberg, B.; Zill, P.; et al. Lower Oxytocin Plasma Levels in Borderline Patients with Unresolved Attachment Representations. Front. Hum. Neurosci. 2016, 10, 125. [Google Scholar] [CrossRef] [Green Version]
  160. Müller, L.E.; Bertsch, K.; Bülau, K.; Herpertz, S.C.; Buchheim, A. Emotional neglect in childhood shapes social dysfunctioning in adults by influencing the oxytocin and the attachment system: Results from a population-based study. Int. J. Psychophysiol. 2019, 136, 73–80. [Google Scholar] [CrossRef]
  161. Fries, A.B.W.; Ziegler, T.E.; Kurian, J.R.; Jacoris, S.; Pollak, S.D. Early experience in humans is associated with changes in neuropeptides critical for regulating social behavior. Proc. Natl. Acad. Sci. USA 2005, 102, 17237–17240. [Google Scholar] [CrossRef] [Green Version]
  162. Julian, M.M.; Rosenblum, K.L.; Doom, J.R.; Leung, C.Y.Y.; Lumeng, J.C.; Cruz, M.G.; Vazquez, D.M.; Miller, A.L. Oxytocin and parenting behavior among impoverished mothers with low vs. high early life stress. Arch. Women’s Ment. Health 2018, 21, 375–382. [Google Scholar] [CrossRef]
  163. Bilbo, S.D.; Schwarz, J.M. The immune system and developmental programming of brain and behavior. Front. Neuroendocrinol. 2012, 33, 267–286. [Google Scholar] [CrossRef] [Green Version]
  164. De Biase, L.M.; Bonci, A. Region-Specific Phenotypes of Microglia: The Role of Local Regulatory Cues. Neuroscientist 2019, 25, 314–333. [Google Scholar] [CrossRef]
  165. Calcia, M.A.; Bonsall, D.R.; Bloomfield, P.S.; Selvaraj, S.; Barichello, T.; Howes, O.D. Stress and neuroinflammation: A systematic review of the effects of stress on microglia and the implications for mental illness. Psychopharmacology 2016, 233, 1637–1650. [Google Scholar] [CrossRef] [Green Version]
  166. Ajami, B.; Bennett, J.L.; Krieger, C.; Tetzlaff, W.; Rossi, F.M.V. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat. Neurosci. 2007, 10, 1538–1543. [Google Scholar] [CrossRef]
  167. Bordt, E.A.; Ceasrine, A.M.; Bilbo, S.D. Microglia and sexual differentiation of the developing brain: A focus on ontogeny and intrinsic factors. Glia 2019, 8, 581–589. [Google Scholar] [CrossRef]
  168. Bordeleau, M.; Carrier, M.; Luheshi, G.N.; Tremblay, M.-È. Microglia along sex lines: From brain colonization, maturation and function, to implication in neurodevelopmental disorders. Semin. Cell Dev. Biol. 2019, 94, 152–163. [Google Scholar] [CrossRef]
  169. Tan, Y.-L.; Yuan, Y.; Tian, L. Microglial regional heterogeneity and its role in the brain. Mol. Psychiatry 2019, 75, 65–71. [Google Scholar] [CrossRef] [Green Version]
  170. Li, Q.; Cheng, Z.; Zhou, L.; Darmanis, S.; Neff, N.F.; Okamoto, J.; Gulati, G.; Bennett, M.L.; Sun, L.O.; Clarke, L.E.; et al. Developmental Heterogeneity of Microglia and Brain Myeloid Cells Revealed by Deep Single-Cell RNA Sequencing. Neuron 2019, 101, 207–223. [Google Scholar] [CrossRef] [Green Version]
  171. Hammond, T.R.; Dufort, C.; Dissing-Olesen, L.; Giera, S.; Young, A.; Wysoker, A.; Walker, A.J.; Gergits, F.; Segel, M.; Nemesh, J.; et al. Single-Cell RNA Sequencing of Microglia throughout the Mouse Lifespan and in the Injured Brain Reveals Complex Cell-State Changes. Immunity 2019, 50, 253–271. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  172. Masuda, T.; Sankowski, R.; Staszewski, O.; Böttcher, C.; Amann, L.; Sagar Scheiwe, C.; Nessler, S.; Kunz, P.; van Loo, G.; Reinacher, P.C.; et al. Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution. Nature 2019, 566, 388–392. [Google Scholar] [CrossRef] [PubMed]
  173. Stratoulias, V.; Venero, J.L.; Tremblay, M.-È.; Joseph, B. Microglial subtypes: Diversity within the microglial community. EMBO J. 2019, 38, e101997. [Google Scholar] [CrossRef]
  174. Gómez-González, B.; Escobar, A. Altered functional development of the blood-brain barrier after early life stress in the rat. Brain Res. Bull. 2009, 79, 376–387. [Google Scholar] [CrossRef] [PubMed]
  175. Mondelli, V.; Vernon, A.C. From early adversities to immune activation in psychiatric disorders: The role of the sympathetic nervous system. Clin. Exp. Immunol. 2019, 197, 319–328. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  176. Jordão, M.J.C.; Sankowski, R.; Brendecke, S.M.; Mai, D.; Locatelli, G.; Tai, Y.-H.; Tay, T.L.; Schramm, E.; Armbruster, S.; Hagemeyer, N.; et al. Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation. Science 2019, 363, eaat7554. [Google Scholar] [CrossRef] [PubMed]
  177. Danese, A.; Lewis, S.J. Psychoneuroimmunology of Early-Life Stress: The Hidden Wounds of Childhood Trauma? Neuropsychopharmacology 2017, 42, 99–114. [Google Scholar] [CrossRef] [Green Version]
  178. Hoogland, I.C.M.; Houbolt, C.; van Westerloo, D.J.; van Gool, W.A.; van de Beek, D. Systemic inflammation and microglial activation: Systematic review of animal experiments. J. Neuroinflamm. 2015, 12, 114. [Google Scholar] [CrossRef] [Green Version]
  179. Haage, V.; Semtner, M.; Vidal, R.O.; Hernandez, D.P.; Pong, W.W.; Chen, Z.; Hambardzumyan, D.; Magrini, V.; Ly, A.; Walker, J.; et al. Comprehensive gene expression meta-analysis identifies signature genes that distinguish microglia from peripheral monocytes/macrophages in health and glioma. Acta Neuropathol. Commun. 2019, 7, 20. [Google Scholar] [CrossRef] [Green Version]
  180. Fogelman, N.; Canli, T. Early Life Stress, Physiology, and Genetics: A Review. Front. Psychol. 2019, 10, 1668. [Google Scholar] [CrossRef]
  181. Madore, C.; Yin, Z.; Leibowitz, J.; Butovsky, O. Microglia, Lifestyle Stress, and Neurodegeneration. Immunity 2020. [Google Scholar] [CrossRef]
Jcm 09 00468 g001 550
Figure 1. Microglia mediate the effects of early life stress (ELS) on brain and behavioral development. E: embryonic day; P: postnatal day.
Figure 1. Microglia mediate the effects of early life stress (ELS) on brain and behavioral development. E: embryonic day; P: postnatal day.
Jcm 09 00468 g001
Table
Table 1. Effects of prenatal ELS on microglial cell density and phenotype and subsequent behavioral alterations.
Table 1. Effects of prenatal ELS on microglial cell density and phenotype and subsequent behavioral alterations.
Type of StressTimeSpecies and SexEarly Effects on MicrogliaLate Effects on MicrogliaBrain RegionMicroglial-Dependent Behavioral EffectsRef
Behavioral stressorsMaternal forced swimE18–P21Rats, M FP1: ↓lectin+cells and amoeboid morphology (in CC); ↑ lectin+ cells (other regions)-CC, PCtx, ECtx, PFC, Sp, BG, Th, Md, IC-[28]
Maternal sleep deprivationE18–P1Rats, M-P21: ↑IBA-1+ cells and retracted thicker processesHIP↓ spatial learning & memory[29,30]
Maternal restraint stress/LPSE12–P21/P120Mouse, FP120: ↑ IBA-1+ cells, ↑ soma size and thick processes/↑ IBA-1+ cells-HIP (CA1/DG)-[31]
Environmental agents and infectionMaternal Poly I:C injectionE15Rat, M-P103: ↑ microglial IL-1β, TNFαHIP↑ startle response in the PPI[34]
E9Mouse, M F-P62: ↑ number, amoeboid IBA-1+ cellsCtx, HIP, Th↑locomotor activity and startle response in the PPI, ↓ sociability[36]
E9.5Mouse, M F-P90: ↑ IBA-1+ cells, ↓ arborization in MPFC, HIP, Cb-[39]
E14.5Mouse, M FP1: adult-like transcriptome P28: no effectWB-[49]
E15Mouse, M P80: ↑IBA-1+ cells, ↓phagocytosis HIP (DG)↑ startle response in the PPI, ↓working memory in novel object recognition[50]
E15Rat, M F-P180:↑ OX-42+ cells (in CC), activated, ↓microglia arborization (in HIP)CC, HIP-[35]
Maternal Poly I:C injection/unpredictable stressE9/P30–40Mouse, M FP41: ↑ CD68+ cells, ↑ soma size- PFC, HIP↑ startle response in the PPI, anxiety-like behavior, amphetamine-induced locomotion[37]
Maternal LPS injectionE9Mouse, M F-P15: ↓ CX3CR1 mRNA in MHIP-[38]
E13.5Mouse, M F-P7: = number of IBA-1+ cellsSCtx-[40]
Maternal high fat diet/limited nestingE13–P21Mouse, M FP21: ↑ CD11b+ and IBA-1+ cells-HIP-[43]
Maternal high fat dietE0–E17Mouse, M FE17 (LPS in vitro): ↑ TNF-α release in M-WB, Plac-[44]
Maternal low protein diet/IL-1βE10–P1/P1-2Rat, M FP4: ↑ microglial inflammatory genes; ↑ IBA-1+ amoeboid cells (in vitro)---WB, Ctx WM-[45]
Maternal alcohol exposureE6–18Mouse, M FE15.5: ↑ IBA-1+ amoeboid cellsP3:↑ IBA-1+ amoeboid cells, ↓ ramifiedPFC-[46]
Diesel exhaust particles exposure/high fat dietE2,5,8,12,16 /P120–183Mouse, M FP183: ↑ CD11b and CX3CR1 mRNA in M-HIP-[47]
Diesel exhaust particles exposureE2,5,8,12,16Mouse, M F-P30: = number of IBA-1+ cells, ↑ cell volume, microglia-neuron interactionPCtx-[48]
Abbreviations: BG: basal ganglia; CA1: cornu ammonis 1; Cb: cerebellum; CC: corpus callosum; CD clusters of differentiation; Ctx: cortex; DG: dentate gyrus; E: embryonic day; ECtx: entorhinal cortex; F: female; HIP: hippocampus; IBA-1: ionized calcium-binding adapter molecule; IC: internal capsule; IL: interleukin; LPS: lipopolysaccharides; M: male; Md: medulla; P: postnatal day; PCtx: parietal cortex; PFC: prefrontal cortex; Plac: placenta; PPI: prepulse inhibition; SCtx: somatosensory cortex; Sp: septum; Th: thalamus; WB: whole brain; WM: white matter.
Table
Table 2. Effects of postnatal behavioral stressors on microglial cell density and phenotype and subsequent behavioral alterations.
Table 2. Effects of postnatal behavioral stressors on microglial cell density and phenotype and subsequent behavioral alterations.
Type of StressTimeSpecies and SexEarly Effects on MicrogliaLate Effects on MicrogliaBrain RegionMicroglial-Dependent Behavioral EffectsRef
Behavioral stressorsGlucocorticoids exposureP3–5Rat, M F-P12: ↓ number (Hortega method)WM-[51]
P0Rat, M FP2, 5: ↓ amoeboid microglia (Hortega method)P10: ↑ branchingCC-[52]
P1,3,5Rat, M FP4,7: ↓ amoeboid OX-42+ cellsP8: ↑ branchingCC-[53,54]
Limited nestingP2–9Mouse, M-P245: ↑ CD68+ cellsHIPCognitive deficits[55]
P2–9Mouse, MP9: ↓ IBA-1+ cells/processes complexity-ECtx/HIP-[56]
Maternal separationP1-14Rat, MP15: ↑ activated IBA-1+ cells -HIP (Hilus)-[57]
P1–21Mouse, MP14: ↑ number, activated IBA-1+ cells; P14, 28: transcriptomic alterations-HIP-[58]
P1–14Rat, MP15: ↓ number, ↑ activated IBA-1+ cells-HIP (Hilus, CA3)-[59]
P3–12Rat, M F P 14: ↑ number, soma size, ↓ arborization area of IBA-1+ cells -Md-[60]
P1–10Rat, MP 10: ↑ IBA-1 IRP20, 30, 60: ↑ IBA-1 IR and mRNA; P40,50: no effectHIP, PFC-[61]
P2–14Rat, M F P15: ↓ in CD11b+ apoptotic cells -VTA, SN (only M)-[62]
P1–21Rat, M-P100: ↑ IBA-1+ cells DS, NAc, HIP (CA3)-[63]
P2–12Rat, M F -P84: ↓ IBA-1 mRNASC-[64]
P2–14Mouse, M-P60: ↑ motility of IBA-1+ cellsSCtx-[65]
Social isolationP14–21Mouse, M F-P70: ↓ number, soma size and processes of IBA-1+ cellsHIP↑ depressive-like behavior[66]
P21–63Rat, MP63: ↑IBA-1 IR, CD11b, ↓ CD200R mRNA-HIP↑ depressive-like behavior[74]
Social defeatP28–37Mouse, MP28/38:↑ IBA-1 IRP80: ↓ IBA-1 IR and IBA-1+ cellsPFCCognitive deficits[67,68]
Social stressP14–21Mouse, M FP22: ↑ IBA-1 IR and IBA-1+ cell number, soma sizeP60: ↓ IBA-1 IR, ↑ soma size and processes complexityVTA↑ cocaine CPP[69]
Social instability stressP30–45Rats, MP33,46: no effects on OX-42+ cells numberP75: no effectsHIP (DG)-[70]
Maternal separation/restraint stressP1–14/P42–56Mouse, MP42: ↑ activated IBA-1+ cells, ↓ CX3CR1 mRNA/P56: ↑ pro-infl, ↓ anti-infl cytokines mRNA and IR-HIP↑ depressive-like and anxiety-like behavior[71]
Maternal separation/mild variable stressP2–21/22–42Rat, FP51: ↑ activated IBA-1+ cells and IBA-1 IR-PFC, HIP-[72]
Maternal separation+food restriction/food restrictionP2–20+P36–55/P36-55Rat, M FP55: ↑ IBA-1 IR both sexes/↑ IBA-1 IR and ramification only in F-PFC-[73]
Maternal separation+handlingP2–20Rat, M F -P60: ↓ CX3CL1 mRNANAc, not HIP↓ morphine CPP and reinstatement[75]
Sleep deprivationP35Mouse, MP38: ↓ CD68 IR, CX3CR1, CD11b and P2Y12 mRNA, ↓ ramification and PSD95 engulfment, no effect on number and CSF1R mRNA-HIP-[76]
Abbreviations: CA3: cornu ammonis 3; CC: corpus callosum; CD clusters of differentiation; CPP: conditioned place preference; Ctx: cortex; DG: dentate gyrus; DS: dorsal striatum; ECtx: entorhinal cortex; F: female; HIP: hippocampus; IBA-1: ionized calcium-binding adapter molecule; IR: immunoreactivity; M: male; Md: medulla; NAc: nucleus accumbens; P: postnatal day; PFC: prefrontal cortex; SC: spinal cord; SCtx: somatosensory cortex; SN: substantia nigra; VTA: ventral tegmental area; WM: white matter.
Table
Table 3. Effects of postnatal environmental agents and infection on microglial cell density and phenotype and subsequent behavioral alterations.
Table 3. Effects of postnatal environmental agents and infection on microglial cell density and phenotype and subsequent behavioral alterations.
Type of StressTimeSpecies and SexEarly Effects on MicrogliaLate Effects on MicrogliaBrain RegionMicroglial-Dependent Behavioral EffectsRef
Environmental agents and infectionAlcohol exposureP7 Rat, M P8: ↑ IBA-1 IR-Ctx-[77]
P2–6Rat, M F P6: ↑CD11b+ cells, IL-6, TNF-α, CSF1R, TLR4 mRNA and epigenetic alterationsP90:↑ IBA-1+ and CD11b+ cells HYP-[78]
P4–9Rat, MP10: ↓ ramification of IBA-1+ cells-HIP-[79]
P35–39Rat, M FP40: ↑ activated IBA-1+ cells-HIP-[80]
P50–71Rat, FP71: ↑ activated OX-6 (CD74)+ cells-HIP-[81]
P3–5Rat, MP6: ↑ amoeboid and ↓ resting IBA-1+ cells-HIP, Cb-[82]
P35–38Rat, MP40: ↑ activated IBA-1+ cells, BrdU+ P65: ↑ activated IBA-1+ cellsHIP-[83]
P4–9Mouse, M FP10: ↑ IBA-1 IR, ↓ processes-PCtx, HIP, Cb-[84]
P3–5Mouse, M FP6: ↓ isolectin+ cells-Cb-[85]
P4Rat, MP5: ↑ CD11b in F, not M-HIP-[86]
P35–90Rat, MP90: ↓ IBA-1+ cells-MCtx-[87]
P7Mouse, M FP8: ↑ amoeboid CX3CR1-GFP/+ cells and CD68 IR; P9: return to control levels-SCtx-[88]
P4-9Mouse, M FP5/10: no effectsP28: no effectsVCtx-[89]
P25–55Rat, M-P80: ↑ in IBA-1+/NF-κB+ cells HIP-[90]
Morphine exposureP37–42Rat, MP43: ↑ microglial TLR4 mRNA and IRP60: ↑ CD11b mRNA after morphine re-exposureNAcReinstatement of morphine CPP[91]
Oxidative Insult (GBR12909)P10-20Mouse, M F -P60:↑IBA-1+ and CD68+ cellsHIP-[92]
Valproate exposureP7 Rat, MP8: ↑ IBA-1+ cells, ↑ ramification-VCtx, HIP, AMY↑ depressive-like and anxiety-like behavior[93]
Methylphenidate exposureP28–55Rats, M FP57: ↓ ramification of IBA-1+ cells, ↓ CX3CR1 mRNA-PFC-[94]
Manganese exposureP20–34,90–150Mouse, M FP35: ↑ameboid IBA-1+ cells, NOS2+; P150: no effect-DS, NAc, SN, GP-[95]
Methylphenidate exposureP21–111Rat, MP112: ↑ [3H] PK 11195 binding-Ctx, Th, GP, SN-[96]
Environmental agents and infectionLPS injectionP3–5Rat, M F P7: ↑ IBA-1+ cells in F-HIP [97]
P4Mouse, M FP7-10: ↑IBA-1 mRNA and IBA-1+ cells-Ret-[98]
P3Rat, M FP6: ↑ IBA-1+ cells, amoeboid-like/rod soma, ↓ ED1, MHC-II, iNOS+ cells, ↑ TGF-β, CD206+ cellsP21: = number, ↑ soma size and ↓ processesHIP, WM, PV -[99]
P2,21Mouse, M FP21 (vs P2): ↑ microglial CD11a, CD172a IR, ↓ SLAMF7 IR-WB-[100]
P14,15Rat, M F-P35: ↑IBA-1+ hypertrophic, apoptotic cellsPFC, HIP-[101]
P6Rat, M-P90: ↑ IBA-1+ cellsPFC-[102]
P3,5Rat, M-P85: ↑IBA-1 soma expressionHIP (CA1, DG)-[103]
P5Rat, F-P71: ↑ OX-42+ cellsHIP (CA1)-[104]
P5Rat, M-P70: ↑ OX-42+ cellsSN-[105]
P5Rat, M-P21: ↑ activated OX-42+ cellsCC, PV↓ neurobehavioral performance[106]
P4–6Mouse, M F P7: ↑ proportion of amoeboid cells, P11: ↓ CX3CR1-GFP+ cellsP13-15: ↑ CX3CR1-GFP+ cells, ↑ proportion of amoeboid cellsPons-[107]
E.Coli/LPS injectionP4/P60Rat, MP5,6,7: ↑ CD11b expression P60: ↑ CD11b mRNA, further ↑ by LPSHIP-[108]
P4/P60Rat, MP6: ↑ number, active and proliferating IBA-1+ cells P33: no changes/P60: ↑ IBA-1+ cells number and volumes, further ↑ by LPSHIP, PCtx (not FC)-[110]
E.Coli/Handling/LPSP4/P4–20/P60Rat, M-P60: ↑ CD11b mRNA, further ↑ by LPS, ↓ by handlingHIP-[109]
E.Coli/AmphetamineP4/P40Rat, M-P40: ↑ CD200 mRNA by amph, ↓ in E.Coli-amphNAc-[111]
E.Coli/LPS+Fear conditioningP4/90Rat, M-P90: ↑ CD11b,↓ CD200, CD200R, CX3CR1 mRNA, ↑ microglial IL-1β mRNA (further ↑ by LPS)HIP ↓ memory performance[112]
Abbreviations: AMY: amygdala; CA1: cornu ammonis 1; Cb: cerebellum; CC: corpus callosum; CD clusters of differentiation; CPP: conditioned place preference; Ctx: cortex; DG: dentate gyrus; DS: dorsal striatum; F: female; GP: globus pallidus; HIP: hippocampus; HYP: hypothalamus; IBA-1: ionized calcium-binding adapter molecule; IL: interleukin; IR: immunoreactivity; LPS: lipopolysaccharides; M: male; MCtx: motor cortex; NAc: nucleus accumbens; P: postnatal day; PCtx: parietal cortex; PFC: prefrontal cortex; PV: periventricular areas; Ret: retina; SCtx: somatosensory cortex; SN: substantia nigra; Th: thalamus; VCtx: Visual cortex; WB: whole brain; WM: white matter.

Share and Cite

MDPI and ACS Style

Catale, C.; Gironda, S.; Lo Iacono, L.; Carola, V. Microglial Function in the Effects of Early-Life Stress on Brain and Behavioral Development. J. Clin. Med. 2020, 9, 468. https://doi.org/10.3390/jcm9020468

AMA Style

Catale C, Gironda S, Lo Iacono L, Carola V. Microglial Function in the Effects of Early-Life Stress on Brain and Behavioral Development. Journal of Clinical Medicine. 2020; 9(2):468. https://doi.org/10.3390/jcm9020468

Chicago/Turabian Style

Catale, Clarissa, Stephen Gironda, Luisa Lo Iacono, and Valeria Carola. 2020. "Microglial Function in the Effects of Early-Life Stress on Brain and Behavioral Development" Journal of Clinical Medicine 9, no. 2: 468. https://doi.org/10.3390/jcm9020468

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop